{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:41:55Z","timestamp":1793234515063,"version":"4.5.0"},"reference-count":316,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Fluids Barriers CNS"],"DOI":"10.1186\/s12987-026-00816-3","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:52:31Z","timestamp":1778583151000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Modeling blood\u2013brain barrier\u2013glioblastoma interactions: implications for chemoresistance and therapeutic targeting"],"prefix":"10.1186","volume":"23","author":[{"given":"Mohamed Abd Naceur","family":"Ammar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Dobiasova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris Chiara","family":"Salaroglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihem","family":"Hmissa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabiha","family":"Missaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Riganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"816_CR1","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1080\/10717544.2019.1616235","volume":"26","author":"D Wang","year":"2019","unstructured":"Wang D, Wang C, Wang L, Chen Y. A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain\/brain tumor barriers for glioblastoma treatment. Drug Deliv. 2019;26:551\u201365. https:\/\/doi.org\/10.1080\/10717544.2019.1616235.","journal-title":"Drug Deliv"},{"key":"816_CR2","doi-asserted-by":"publisher","first-page":"3905","DOI":"10.3390\/cancers17243905","volume":"17","author":"D Buist","year":"2025","unstructured":"Buist D, van der Weide H, Bergink S, Chiu R. A Theoretical Framework for Ligand-Functionalised Magnetic Lipid Nanoparticles in Glioblastoma Therapy. Cancers (Basel). 2025;17:3905. https:\/\/doi.org\/10.3390\/cancers17243905.","journal-title":"Cancers (Basel)"},{"key":"816_CR3","doi-asserted-by":"publisher","first-page":"e49405","DOI":"10.7554\/eLife.49405","volume":"8","author":"M Mathiesen Janiurek","year":"2019","unstructured":"Mathiesen Janiurek M, Soylu-Kucharz R, Christoffersen C, Kucharz K, Lauritzen M. Apolipoprotein M-bound sphingosine-1-phosphate regulates blood-brain barrier paracellular permeability and transcytosis. Elife. 2019;8:e49405. https:\/\/doi.org\/10.7554\/eLife.49405.","journal-title":"Elife"},{"key":"816_CR4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.bbrc.2022.06.083","volume":"620","author":"W Kim","year":"2022","unstructured":"Kim W, Kim J, Lee S-Y, Kim H-M, Joo KM, Nam D-H. Simplified in vitro 3D co-culture-based blood-brain barrier model using transwell. Biochem Biophys Res Commun. 2022;620:63\u20138. https:\/\/doi.org\/10.1016\/j.bbrc.2022.06.083.","journal-title":"Biochem Biophys Res Commun"},{"key":"816_CR5","doi-asserted-by":"publisher","first-page":"116931","DOI":"10.1016\/j.bcp.2025.116931","volume":"237","author":"G Dabkevi\u010di\u016bt\u0117","year":"2025","unstructured":"Dabkevi\u010di\u016bt\u0117 G, Petrikait\u0117 V. Insights into 2D and 3D cell culture models for nanoparticle-based drug delivery to glioblastoma. Biochem Pharmacol. 2025;237:116931. https:\/\/doi.org\/10.1016\/j.bcp.2025.116931.","journal-title":"Biochem Pharmacol"},{"key":"816_CR6","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s11060-014-1514-2","volume":"119","author":"C Leten","year":"2014","unstructured":"Leten C, Struys T, Dresselaers T, Himmelreich U. In vivo and ex vivo assessment of the blood brain barrier integrity in different glioblastoma animal models. J Neurooncol. 2014;119:297\u2013306. https:\/\/doi.org\/10.1007\/s11060-014-1514-2.","journal-title":"J Neurooncol"},{"key":"816_CR7","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","volume":"8","author":"D Wu","year":"2023","unstructured":"Wu D, Chen Q, Chen X, Han F, Chen Z, Wang Y. The blood-brain barrier: structure, regulation, and drug delivery. Signal Transduct Target Ther. 2023;8:217. https:\/\/doi.org\/10.1038\/s41392-023-01481-w.","journal-title":"Signal Transduct Target Ther"},{"key":"816_CR8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12987-020-00230-3","volume":"17","author":"H Kadry","year":"2020","unstructured":"Kadry H, Noorani B, Cucullo L. A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity. Fluids Barriers CNS. 2020;17:69. https:\/\/doi.org\/10.1186\/s12987-020-00230-3.","journal-title":"Fluids Barriers CNS"},{"key":"816_CR9","doi-asserted-by":"publisher","unstructured":"Katdare KA, Kjar A, O\u2019Brown NM, Neal EH, Sorets AG, Shostak A, et al. IQGAP2 regulates blood-brain barrier immune dynamics. iScience [Internet]. Elsevier; 2025 [cited 2025 Jun 22];28. https:\/\/doi.org\/10.1016\/j.isci.2025.111994.","DOI":"10.1016\/j.isci.2025.111994"},{"key":"816_CR10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/ijc.33965","volume":"151","author":"E Petrosyan","year":"2022","unstructured":"Petrosyan E, Fares J, Cordero A, Rashidi A, Arrieta VA, Kanojia D, et al. Repurposing autophagy regulators in brain tumors. Int J Cancer. 2022;151:167\u201380. https:\/\/doi.org\/10.1002\/ijc.33965.","journal-title":"Int J Cancer"},{"key":"816_CR11","doi-asserted-by":"publisher","first-page":"18","DOI":"10.2174\/1871527321666220222092655","volume":"22","author":"B Hasannejad-Asl","year":"2023","unstructured":"Hasannejad-Asl B, Pooresmaeil F, Choupani E, Dabiri M, Behmardi A, Fadaie M, et al. Nanoparticles as Powerful Tools for Crossing the Blood-brain Barrier. CNS Neurol Disord Drug Targets. 2023;22:18\u201326. https:\/\/doi.org\/10.2174\/1871527321666220222092655.","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"816_CR12","unstructured":"Wasielewska JM, Da Silva Chaves JC, White AR, Oikari LE. Modeling the blood\u2013brain barrier to understand drug delivery in Alzheimer\u2019s disease. In: Huang X, editor. Alzheimer\u2019s Disease: Drug Discovery [Internet]. Brisbane (AU): Exon Publications; 2020 [cited 2026 Jan 17]. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK566120\/. Accessed 17 Jan 2026."},{"key":"816_CR13","unstructured":"Zhang L, Zoidl GR, Carlen PL. Connexins, Pannexins, and Epilepsy. In: Noebels JL, Avoli M, Rogawski MA, Vezzani A, Delgado-Escueta AV, editors. Jasper\u2019s Basic mechanisms of the epilepsies [Internet]. 5th ed. New York: Oxford University Press; 2024 [cited 2026 Jan 17]. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK609905\/. Accessed 17 Jan 2026."},{"key":"816_CR14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/bs.vh.2024.04.006","volume":"126","author":"S Michinaga","year":"2024","unstructured":"Michinaga S, Hishinuma S, Koyama Y. Roles of astrocytic sonic hedgehog production and its signal for regulation of the blood-brain barrier permeability. Vitam Horm. 2024;126:97\u2013111. https:\/\/doi.org\/10.1016\/bs.vh.2024.04.006.","journal-title":"Vitam Horm"},{"key":"816_CR15","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1093\/brain\/awab311","volume":"145","author":"MM Salman","year":"2022","unstructured":"Salman MM, Kitchen P, Halsey A, Wang MX, T\u00f6rnroth-Horsefield S, Conner AC, et al. Emerging roles for dynamic aquaporin-4 subcellular relocalization in CNS water homeostasis. Brain. 2022;145:64\u201375. https:\/\/doi.org\/10.1093\/brain\/awab311.","journal-title":"Brain"},{"key":"816_CR16","doi-asserted-by":"publisher","first-page":"3819","DOI":"10.1016\/j.neuron.2023.08.030","volume":"111","author":"K Pandey","year":"2023","unstructured":"Pandey K, Bessi\u00e8res B, Sheng SL, Taranda J, Osten P, Sandovici I, et al. Neuronal activity drives IGF2 expression from pericytes to form long-term memory. Neuron. 2023;111:3819\u2013e38368. https:\/\/doi.org\/10.1016\/j.neuron.2023.08.030.","journal-title":"Neuron"},{"key":"816_CR17","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/nn.4489","volume":"20","author":"K Kisler","year":"2017","unstructured":"Kisler K, Nelson AR, Rege SV, Ramanathan A, Wang Y, Ahuja A, et al. Pericyte degeneration leads to neurovascular uncoupling and limits oxygen supply to brain. Nat Neurosci. 2017;20:406\u201316. https:\/\/doi.org\/10.1038\/nn.4489.","journal-title":"Nat Neurosci"},{"key":"816_CR18","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1038\/s41467-017-01738-3","volume":"8","author":"HM Eilken","year":"2017","unstructured":"Eilken HM, Di\u00e9guez-Hurtado R, Schmidt I, Nakayama M, Jeong H-W, Arf H, et al. Pericytes regulate VEGF-induced endothelial sprouting through VEGFR1. Nat Commun. 2017;8:1574. https:\/\/doi.org\/10.1038\/s41467-017-01738-3.","journal-title":"Nat Commun"},{"key":"816_CR19","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/s41593-019-0434-z","volume":"22","author":"AM Nikolakopoulou","year":"2019","unstructured":"Nikolakopoulou AM, Montagne A, Kisler K, Dai Z, Wang Y, Huuskonen MT, et al. Pericyte loss leads to circulatory failure and pleiotrophin depletion causing neuron loss. Nat Neurosci. 2019;22:1089\u201398. https:\/\/doi.org\/10.1038\/s41593-019-0434-z.","journal-title":"Nat Neurosci"},{"key":"816_CR20","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/nature21724","volume":"544","author":"L Tian","year":"2017","unstructured":"Tian L, Goldstein A, Wang H, Ching Lo H, Sun Kim I, Welte T, et al. Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming. Nature. 2017;544:250\u20134. https:\/\/doi.org\/10.1038\/nature21724.","journal-title":"Nature"},{"key":"816_CR21","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/s41419-022-05025-y","volume":"13","author":"F Pisani","year":"2022","unstructured":"Pisani F, Castagnola V, Simone L, Loiacono F, Svelto M, Benfenati F. Role of pericytes in blood-brain barrier preservation during ischemia through tunneling nanotubes. Cell Death Dis. 2022;13:582. https:\/\/doi.org\/10.1038\/s41419-022-05025-y.","journal-title":"Cell Death Dis"},{"key":"816_CR22","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.3390\/biom12091174","volume":"12","author":"SF Spampinato","year":"2022","unstructured":"Spampinato SF, Costantino G, Merlo S, Canonico PL, Sortino MA. Microglia Contributes to BAF-312 Effects on Blood-Brain Barrier Stability. Biomolecules. 2022;12:1174. https:\/\/doi.org\/10.3390\/biom12091174.","journal-title":"Biomolecules"},{"key":"816_CR23","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.molmed.2019.08.013","volume":"25","author":"EC Wright-Jin","year":"2019","unstructured":"Wright-Jin EC, Gutmann DH. Microglia as Dynamic Cellular Mediators of Brain Function. Trends Mol Med. 2019;25:967\u201379. https:\/\/doi.org\/10.1016\/j.molmed.2019.08.013.","journal-title":"Trends Mol Med"},{"key":"816_CR24","doi-asserted-by":"publisher","first-page":"dev200425","DOI":"10.1242\/dev.200425","volume":"149","author":"LC Mehl","year":"2022","unstructured":"Mehl LC, Manjally AV, Bouadi O, Gibson EM, Tay TL. Microglia in brain development and regeneration. Development. 2022;149:dev200425. https:\/\/doi.org\/10.1242\/dev.200425.","journal-title":"Development"},{"key":"816_CR25","doi-asserted-by":"publisher","first-page":"913","DOI":"10.11477\/mf.1416201861","volume":"73","author":"A Ikegami","year":"2021","unstructured":"Ikegami A, Wake H. [Microglial Regulation of Blood Brain Barrier, the Neuro-Immunological Interface]. Brain Nerve. 2021;73:913\u20139. https:\/\/doi.org\/10.11477\/mf.1416201861.","journal-title":"Brain Nerve"},{"key":"816_CR26","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.3389\/fimmu.2019.01455","volume":"10","author":"JW Yun","year":"2019","unstructured":"Yun JW, Barzegar M, Boyer CJ, Minagar A, Couraud P-O, Alexander JS. Brain Endothelial Cells Release Apical and Basolateral Microparticles in Response to Inflammatory Cytokine Stimulation: Relevance to Neuroinflammatory Stress? Front Immunol. 2019;10:1455. https:\/\/doi.org\/10.3389\/fimmu.2019.01455.","journal-title":"Front Immunol"},{"key":"816_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22126385","author":"MA Dymova","year":"2021","unstructured":"Dymova MA, Kuligina EV, Richter VA. Molecular Mechanisms of Drug Resistance in Glioblastoma. Int J Mol Sci [Internet]. Multidisciplinary Digital Publishing Institute (MDPI); 2021 [cited 2024 Mar 25];22. https:\/\/doi.org\/10.3390\/ijms22126385."},{"key":"816_CR28","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s41578-021-00394-w","volume":"7","author":"E Nance","year":"2022","unstructured":"Nance E, Pun SH, Saigal R, Sellers DL. Drug delivery to the central nervous system. Nat Rev Mater. 2022;7:314\u201331. https:\/\/doi.org\/10.1038\/s41578-021-00394-w.","journal-title":"Nat Rev Mater"},{"key":"816_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/neurolint18010001","volume":"18","author":"E Suleymanova","year":"2025","unstructured":"Suleymanova E, Karan A. The Role of Blood-Brain Barrier Disruption in Epilepsy: Mechanisms and Consequences. Neurol Int. 2025;18:1. https:\/\/doi.org\/10.3390\/neurolint18010001.","journal-title":"Neurol Int"},{"key":"816_CR30","doi-asserted-by":"publisher","unstructured":"Lahariya R, Sinha M, Kumari B, Subramanian KV, Anand G. Time-dependent neurovascular unit dysfunction in ischemic stroke: mechanisms of neurovascular uncoupling and its clinical impact. Int J Neurosci. 2026;1\u201312. https:\/\/doi.org\/10.1080\/00207454.2026.2627246.","DOI":"10.1080\/00207454.2026.2627246"},{"key":"816_CR31","doi-asserted-by":"publisher","unstructured":"Emery CEG, Love S, Miners JS. New perspectives on VEGF signalling in Alzheimer\u2019s disease. Brain Pathol Zurich Switz. 2026;e70100. https:\/\/doi.org\/10.1111\/bpa.70100.","DOI":"10.1111\/bpa.70100"},{"key":"816_CR32","doi-asserted-by":"publisher","first-page":"1741928","DOI":"10.3389\/fncel.2026.1741928","volume":"20","author":"J Gowdy","year":"2026","unstructured":"Gowdy J, Ahn J, Miller RH, Islam Y. Neurovascular dysfunction in the development and progression of neuroinflammatory diseases. Front Cell Neurosci. 2026;20:1741928. https:\/\/doi.org\/10.3389\/fncel.2026.1741928.","journal-title":"Front Cell Neurosci"},{"key":"816_CR33","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1097\/CCO.0000000000000417","volume":"30","author":"G Seano","year":"2018","unstructured":"Seano G. Targeting the perivascular niche in brain tumors. Curr Opin Oncol. 2018;30:54\u201360. https:\/\/doi.org\/10.1097\/CCO.0000000000000417.","journal-title":"Curr Opin Oncol"},{"key":"816_CR34","doi-asserted-by":"publisher","unstructured":"X L, C JT. W, G H, Y C, J H, GPNMB Drives brain metastasis by sculpting a pathological endothelial-immune interactome. Cancer discovery [Internet]. Cancer Discov; 2026 [cited 2026 Apr 25]; https:\/\/doi.org\/10.1158\/2159-8290.CD-25-1663.","DOI":"10.1158\/2159-8290.CD-25-1663"},{"key":"816_CR35","doi-asserted-by":"publisher","first-page":"e70070","DOI":"10.1002\/jex2.70070","volume":"4","author":"Correction to Journal of Extracellular Biology Articles","year":"2025","unstructured":"Correction to Journal of Extracellular Biology Articles. J Extracell Biol. 2025;4:e70070. https:\/\/doi.org\/10.1002\/jex2.70070.","journal-title":"J Extracell Biol"},{"key":"816_CR36","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1038\/jcbfm.2014.100","volume":"34","author":"ML Pinz\u00f3n-Daza","year":"2014","unstructured":"Pinz\u00f3n-Daza ML, Salaroglio IC, Kopecka J, Garz\u00f2n R, Couraud P-O, Ghigo D, et al. The cross-talk between canonical and non-canonical Wnt-dependent pathways regulates P-glycoprotein expression in human blood-brain barrier cells. J Cereb Blood Flow Metab. 2014;34:1258\u201369. https:\/\/doi.org\/10.1038\/jcbfm.2014.100.","journal-title":"J Cereb Blood Flow Metab"},{"key":"816_CR37","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s40478-025-01983-4","volume":"13","author":"L Liu","year":"2025","unstructured":"Liu L, He Y, Du H, Tang M, Wang T, Tan J, et al. Biological profile of breast cancer brain metastasis. Acta Neuropathol Commun. 2025;13:78. https:\/\/doi.org\/10.1186\/s40478-025-01983-4.","journal-title":"Acta Neuropathol Commun"},{"key":"816_CR38","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12987-024-00590-0","volume":"21","author":"S Digiovanni","year":"2024","unstructured":"Digiovanni S, Lorenzati M, Bianciotto OT, Godel M, Fontana S, Akman M, et al. Blood-brain barrier permeability increases with the differentiation of glioblastoma cells in vitro. Fluids Barriers CNS. 2024;21:89. https:\/\/doi.org\/10.1186\/s12987-024-00590-0.","journal-title":"Fluids Barriers CNS"},{"key":"816_CR39","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00018-013-1397-y","volume":"71","author":"C Riganti","year":"2014","unstructured":"Riganti C, Salaroglio IC, Pinz\u00f2n-Daza ML, Caldera V, Campia I, Kopecka J, et al. Temozolomide down-regulates P-glycoprotein in human blood-brain barrier cells by disrupting Wnt3 signaling. Cell Mol Life Sci. 2014;71:499\u2013516. https:\/\/doi.org\/10.1007\/s00018-013-1397-y.","journal-title":"Cell Mol Life Sci"},{"key":"816_CR40","doi-asserted-by":"publisher","first-page":"36450","DOI":"10.1038\/srep36450","volume":"6","author":"J Gautam","year":"2016","unstructured":"Gautam J, Zhang X, Yao Y. The role of pericytic laminin in blood brain barrier integrity maintenance. Sci Rep. 2016;6:36450. https:\/\/doi.org\/10.1038\/srep36450.","journal-title":"Sci Rep"},{"key":"816_CR41","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1038\/ncomms4413","volume":"5","author":"Y Yao","year":"2014","unstructured":"Yao Y, Chen Z-L, Norris EH, Strickland S. Astrocytic laminin regulates pericyte differentiation and maintains blood brain barrier integrity. Nat Commun. 2014;5:3413. https:\/\/doi.org\/10.1038\/ncomms4413.","journal-title":"Nat Commun"},{"key":"816_CR42","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.3390\/cells11182823","volume":"11","author":"Y Sato","year":"2022","unstructured":"Sato Y, Falcone-Juengert J, Tominaga T, Su H, Liu J. Remodeling of the Neurovascular Unit Following Cerebral Ischemia and Hemorrhage. Cells. 2022;11:2823. https:\/\/doi.org\/10.3390\/cells11182823.","journal-title":"Cells"},{"key":"816_CR43","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/acel.12045","volume":"12","author":"CA Hawkes","year":"2013","unstructured":"Hawkes CA, Gatherer M, Sharp MM, Dorr A, Yuen HM, Kalaria R, et al. Regional differences in the morphological and functional effects of aging on cerebral basement membranes and perivascular drainage of amyloid-\u03b2 from the mouse brain. Aging Cell. 2013;12:224\u201336. https:\/\/doi.org\/10.1111\/acel.12045.","journal-title":"Aging Cell"},{"key":"816_CR44","doi-asserted-by":"publisher","first-page":"8404","DOI":"10.3390\/ijms25158404","volume":"25","author":"C Dancy","year":"2024","unstructured":"Dancy C, Heintzelman KE, Katt ME. The Glycocalyx: The Importance of Sugar Coating the Blood-Brain Barrier. IJMS. 2024;25:8404. https:\/\/doi.org\/10.3390\/ijms25158404.","journal-title":"IJMS"},{"key":"816_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-319-96445-4_1","volume":"1097","author":"Y Zeng","year":"2018","unstructured":"Zeng Y, Zhang XF, Fu BM, Tarbell JM. The Role of Endothelial Surface Glycocalyx in Mechanosensing and Transduction. Adv Exp Med Biol. 2018;1097:1\u201327. https:\/\/doi.org\/10.1007\/978-3-319-96445-4_1.","journal-title":"Adv Exp Med Biol"},{"key":"816_CR46","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.1002\/cphy.c210029","volume":"12","author":"CA Foote","year":"2022","unstructured":"Foote CA, Soares RN, Ramirez-Perez FI, Ghiarone T, Aroor A, Manrique-Acevedo C, et al. Endothelial Glycocalyx Compr Physiol. 2022;12:3781\u2013811. https:\/\/doi.org\/10.1002\/cphy.c210029.","journal-title":"Endothelial Glycocalyx Compr Physiol"},{"key":"816_CR47","doi-asserted-by":"publisher","first-page":"17523","DOI":"10.1038\/s41598-018-35976-2","volume":"8","author":"Y Ando","year":"2018","unstructured":"Ando Y, Okada H, Takemura G, Suzuki K, Takada C, Tomita H, et al. Brain-Specific Ultrastructure of Capillary Endothelial Glycocalyx and Its Possible Contribution for Blood Brain Barrier. Sci Rep. 2018;8:17523. https:\/\/doi.org\/10.1038\/s41598-018-35976-2.","journal-title":"Sci Rep"},{"key":"816_CR48","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/s41586-025-08589-9","volume":"639","author":"SM Shi","year":"2025","unstructured":"Shi SM, Suh RJ, Shon DJ, Garcia FJ, Buff JK, Atkins M, et al. Glycocalyx dysregulation impairs blood-brain barrier in ageing and disease. Nature. 2025;639:985\u201394. https:\/\/doi.org\/10.1038\/s41586-025-08589-9.","journal-title":"Nature"},{"key":"816_CR49","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.ajpath.2019.11.015","volume":"190","author":"MJ Butler","year":"2020","unstructured":"Butler MJ, Down CJ, Foster RR, Satchell SC. The Pathological Relevance of Increased Endothelial Glycocalyx Permeability. Am J Pathol. 2020;190:742\u201351. https:\/\/doi.org\/10.1016\/j.ajpath.2019.11.015.","journal-title":"Am J Pathol"},{"key":"816_CR50","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/978-1-0716-1708-3_18","volume":"2375","author":"BM Fu","year":"2022","unstructured":"Fu BM. Quantification of In Vitro Blood-Brain Barrier Permeability. Methods Mol Biol. 2022;2375:217\u201328. https:\/\/doi.org\/10.1007\/978-1-0716-1708-3_18.","journal-title":"Methods Mol Biol"},{"key":"816_CR51","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s10545-013-9608-0","volume":"36","author":"NJ Abbott","year":"2013","unstructured":"Abbott NJ. Blood-brain barrier structure and function and the challenges for CNS drug delivery. J Inherit Metab Dis. 2013;36:437\u201349. https:\/\/doi.org\/10.1007\/s10545-013-9608-0.","journal-title":"J Inherit Metab Dis"},{"key":"816_CR52","doi-asserted-by":"publisher","first-page":"706","DOI":"10.3390\/pharmaceutics17060706","volume":"17","author":"L Ding","year":"2025","unstructured":"Ding L, Kshirsagar P, Agrawal P, Murry DJ. Crossing the Blood-Brain Barrier: Innovations in Receptor- and Transporter-Mediated Transcytosis Strategies. Pharmaceutics. 2025;17:706. https:\/\/doi.org\/10.3390\/pharmaceutics17060706.","journal-title":"Pharmaceutics"},{"key":"816_CR53","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neuron.2008.01.003","volume":"57","author":"BV Zlokovic","year":"2008","unstructured":"Zlokovic BV. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron. 2008;57:178\u2013201. https:\/\/doi.org\/10.1016\/j.neuron.2008.01.003.","journal-title":"Neuron"},{"key":"816_CR54","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/nn.3966","volume":"18","author":"EA Winkler","year":"2015","unstructured":"Winkler EA, Nishida Y, Sagare AP, Rege SV, Bell RD, Perlmutter D, et al. GLUT1 reductions exacerbate Alzheimer\u2019s disease vasculo-neuronal dysfunction and degeneration. Nat Neurosci. 2015;18:521\u201330. https:\/\/doi.org\/10.1038\/nn.3966.","journal-title":"Nat Neurosci"},{"key":"816_CR55","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.yebeh.2018.06.010","volume":"91","author":"H Koch","year":"2019","unstructured":"Koch H, Weber YG. The glucose transporter type 1 (Glut1) syndromes. Epilepsy Behav. 2019;91:90\u20133. https:\/\/doi.org\/10.1016\/j.yebeh.2018.06.010.","journal-title":"Epilepsy Behav"},{"key":"816_CR56","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12987-024-00526-8","volume":"21","author":"S Chasseigneaux","year":"2024","unstructured":"Chasseigneaux S, Cochois-Gu\u00e9gan V, Lecorgne L, Lochus M, Nicolic S, Blugeon C, et al. Fasting upregulates the monocarboxylate transporter MCT1 at the rat blood-brain barrier through PPAR \u03b4 activation. Fluids Barriers CNS. 2024;21:33. https:\/\/doi.org\/10.1186\/s12987-024-00526-8.","journal-title":"Fluids Barriers CNS"},{"key":"816_CR57","first-page":"1281","volume":"5","author":"Q Wang","year":"2015","unstructured":"Wang Q, Holst J. L-type amino acid transport and cancer: targeting the mTORC1 pathway to inhibit neoplasia. Am J Cancer Res. 2015;5:1281\u201394.","journal-title":"Am J Cancer Res"},{"key":"816_CR58","doi-asserted-by":"publisher","first-page":"25572","DOI":"10.1038\/s41598-024-77040-2","volume":"14","author":"K Schoknecht","year":"2024","unstructured":"Schoknecht K, Eilers J. Brain-to-blood transport of fluorescein in vitro. Sci Rep. 2024;14:25572. https:\/\/doi.org\/10.1038\/s41598-024-77040-2.","journal-title":"Sci Rep"},{"key":"816_CR59","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nrd3028","volume":"9","author":"KM Giacomini","year":"2010","unstructured":"International Transporter Consortium, Giacomini KM, Huang S-M, Tweedie DJ, Benet LZ, Brouwer KLR, et al. Membrane transporters in drug development. Nat Rev Drug Discov. 2010;9:215\u201336. https:\/\/doi.org\/10.1038\/nrd3028.","journal-title":"Nat Rev Drug Discov"},{"key":"816_CR60","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.phrs.2015.12.024","volume":"104","author":"J-Z Wang","year":"2016","unstructured":"Wang J-Z, Xiao N, Zhang Y-Z, Zhao C-X, Guo X-H, Lu L-M. Mfsd2a-based pharmacological strategies for drug delivery across the blood-brain barrier. Pharmacol Res. 2016;104:124\u201331. https:\/\/doi.org\/10.1016\/j.phrs.2015.12.024.","journal-title":"Pharmacol Res"},{"key":"816_CR61","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s43856-023-00383-w","volume":"3","author":"C-H Chang","year":"2023","unstructured":"Chang C-H, Peng W-Y, Lee W-H, Yang L, Lin T-Y, Yang M-H, et al. Transporter modulation of molnupiravir and its metabolite \u03b2-D-N4-hydroxycytidine across the blood-brain barrier in a rat. Commun Med (Lond). 2023;3:150. https:\/\/doi.org\/10.1038\/s43856-023-00383-w.","journal-title":"Commun Med (Lond)"},{"key":"816_CR62","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41568-019-0205-x","volume":"20","author":"CD Arvanitis","year":"2020","unstructured":"Arvanitis CD, Ferraro GB, Jain RK. The blood-brain barrier and blood-tumour barrier in brain tumours and metastases. Nat Rev Cancer. 2020;20:26\u201341. https:\/\/doi.org\/10.1038\/s41568-019-0205-x.","journal-title":"Nat Rev Cancer"},{"key":"816_CR63","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nrd4626","volume":"14","author":"L Lin","year":"2015","unstructured":"Lin L, Yee SW, Kim RB, Giacomini KM. SLC transporters as therapeutic targets: emerging opportunities. Nat Rev Drug Discov. 2015;14:543\u201360. https:\/\/doi.org\/10.1038\/nrd4626.","journal-title":"Nat Rev Drug Discov"},{"key":"816_CR64","doi-asserted-by":"publisher","first-page":"1360302","DOI":"10.3389\/fddev.2024.1360302","volume":"4","author":"AS Haqqani","year":"2024","unstructured":"Haqqani AS, B\u00e9langer K, Stanimirovic DB. Receptor-mediated transcytosis for brain delivery of therapeutics: receptor classes and criteria. Front Drug Deliv. 2024;4:1360302. https:\/\/doi.org\/10.3389\/fddev.2024.1360302.","journal-title":"Front Drug Deliv"},{"key":"816_CR65","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3390\/pharmaceutics14030672","volume":"14","author":"H Choi","year":"2022","unstructured":"Choi H, Choi K, Kim D-H, Oh B-K, Yim H, Jo S, et al. Strategies for Targeted Delivery of Exosomes to the Brain: Advantages and Challenges. Pharmaceutics. 2022;14:672. https:\/\/doi.org\/10.3390\/pharmaceutics14030672.","journal-title":"Pharmaceutics"},{"key":"816_CR66","doi-asserted-by":"publisher","first-page":"9793","DOI":"10.3390\/ijms26199793","volume":"26","author":"X Shen","year":"2025","unstructured":"Shen X, Li H, Zhang B, Li Y, Zhu Z. Targeting Transferrin Receptor 1 for Enhancing Drug Delivery Through the Blood-Brain Barrier for Alzheimer\u2019s Disease. Int J Mol Sci. 2025;26:9793. https:\/\/doi.org\/10.3390\/ijms26199793.","journal-title":"Int J Mol Sci"},{"key":"816_CR67","doi-asserted-by":"publisher","first-page":"e0252341","DOI":"10.1371\/journal.pone.0252341","volume":"16","author":"C McQuaid","year":"2021","unstructured":"McQuaid C, Halsey A, Dubois M, Romero I, Male D. Comparison of polypeptides that bind the transferrin receptor for targeting gold nanocarriers. PLoS ONE. 2021;16:e0252341. https:\/\/doi.org\/10.1371\/journal.pone.0252341.","journal-title":"PLoS ONE"},{"key":"816_CR68","doi-asserted-by":"publisher","first-page":"e2307899120","DOI":"10.1073\/pnas.2307899120","volume":"120","author":"Z Cheng","year":"2023","unstructured":"Cheng Z, Zheng Y, Yang W, Sun H, Zhou F, Huang C, et al. Pathogenic bacteria exploit transferrin receptor transcytosis to penetrate the blood-brain barrier. Proc Natl Acad Sci U S A. 2023;120:e2307899120. https:\/\/doi.org\/10.1073\/pnas.2307899120.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"816_CR69","doi-asserted-by":"publisher","first-page":"30613","DOI":"10.1038\/s41598-024-83627-6","volume":"14","author":"I Petersen","year":"2024","unstructured":"Petersen I, Morrison JI, Petrovic A, Babic N, Metzendorf NG, Godec A, et al. A shorter linker in the bispecific antibody RmAb158-scFv8D3 improves TfR-mediated blood-brain barrier transcytosis in vitro. Sci Rep. 2024;14:30613. https:\/\/doi.org\/10.1038\/s41598-024-83627-6.","journal-title":"Sci Rep"},{"key":"816_CR70","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/bs.vh.2024.02.002","volume":"126","author":"EM Rhea","year":"2024","unstructured":"Rhea EM, Banks WA. Insulin and the blood-brain barrier. Vitam Horm. 2024;126:169\u201390. https:\/\/doi.org\/10.1016\/bs.vh.2024.02.002.","journal-title":"Vitam Horm"},{"key":"816_CR71","doi-asserted-by":"publisher","first-page":"3410","DOI":"10.1038\/s41467-025-58746-x","volume":"16","author":"K Tang","year":"2025","unstructured":"Tang K, Tang Z, Niu M, Kuang Z, Xue W, Wang X, et al. Allosteric targeted drug delivery for enhanced blood-brain barrier penetration via mimicking transmembrane domain interactions. Nat Commun. 2025;16:3410. https:\/\/doi.org\/10.1038\/s41467-025-58746-x.","journal-title":"Nat Commun"},{"key":"816_CR72","doi-asserted-by":"publisher","first-page":"8384","DOI":"10.3390\/ijms23158384","volume":"23","author":"D-Y Hong","year":"2022","unstructured":"Hong D-Y, Lee D-H, Lee J-Y, Lee E-C, Park S-W, Lee M-R, et al. Relationship between Brain Metabolic Disorders and Cognitive Impairment: LDL Receptor Defect. Int J Mol Sci. 2022;23:8384. https:\/\/doi.org\/10.3390\/ijms23158384.","journal-title":"Int J Mol Sci"},{"key":"816_CR73","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.brainres.2008.10.036","volume":"1249","author":"F Gosselet","year":"2009","unstructured":"Gosselet F, Candela P, Sevin E, Berezowski V, Cecchelli R, Fenart L. Transcriptional profiles of receptors and transporters involved in brain cholesterol homeostasis at the blood-brain barrier: use of an in vitro model. Brain Res. 2009;1249:34\u201342. https:\/\/doi.org\/10.1016\/j.brainres.2008.10.036.","journal-title":"Brain Res"},{"key":"816_CR74","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.drudis.2021.02.008","volume":"26","author":"S Pawar","year":"2021","unstructured":"Pawar S, Koneru T, McCord E, Tatiparti K, Sau S, Iyer AK. LDL receptors and their role in targeted therapy for glioma: a review. Drug Discov Today. 2021;26:1212\u201325. https:\/\/doi.org\/10.1016\/j.drudis.2021.02.008.","journal-title":"Drug Discov Today"},{"key":"816_CR75","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","volume":"32","author":"WM Pardridge","year":"2012","unstructured":"Pardridge WM. Drug transport across the blood-brain barrier. J Cereb Blood Flow Metab. 2012;32:1959\u201372. https:\/\/doi.org\/10.1038\/jcbfm.2012.126.","journal-title":"J Cereb Blood Flow Metab"},{"key":"816_CR76","doi-asserted-by":"publisher","first-page":"119582","DOI":"10.1016\/j.ijpharm.2020.119582","volume":"586","author":"M Azarmi","year":"2020","unstructured":"Azarmi M, Maleki H, Nikkam N, Malekinejad H. Transcellular brain drug delivery: A review on recent advancements. Int J Pharm. 2020;586:119582. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119582.","journal-title":"Int J Pharm"},{"key":"816_CR77","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12987-025-00637-w","volume":"22","author":"RT Chang","year":"2025","unstructured":"Chang RT, Fisher MJ, Sumbria RK. Brain endothelial cells as phagocytes: mechanisms and implications. Fluids Barriers CNS. 2025;22:30. https:\/\/doi.org\/10.1186\/s12987-025-00637-w.","journal-title":"Fluids Barriers CNS"},{"key":"816_CR78","doi-asserted-by":"publisher","first-page":"23662","DOI":"10.1074\/jbc.M109.026229","volume":"284","author":"S Lee","year":"2009","unstructured":"Lee S, Bowrin K, Hamad AR, Chakravarti S. Extracellular matrix lumican deposited on the surface of neutrophils promotes migration by binding to beta2 integrin. J Biol Chem. 2009;284:23662\u20139. https:\/\/doi.org\/10.1074\/jbc.M109.026229.","journal-title":"J Biol Chem"},{"key":"816_CR79","doi-asserted-by":"publisher","first-page":"3124","DOI":"10.1158\/2767-9764.CRC-24-0164","volume":"4","author":"LM Knowles","year":"2024","unstructured":"Knowles LM, Wolter C, Linsler S, M\u00fcller S, Urbschat S, Ketter R, et al. Clotting Promotes Glioma Growth and Infiltration Through Activation of Focal Adhesion Kinase. Cancer Res Commun. 2024;4:3124\u201336. https:\/\/doi.org\/10.1158\/2767-9764.CRC-24-0164.","journal-title":"Cancer Res Commun"},{"key":"816_CR80","doi-asserted-by":"publisher","first-page":"888","DOI":"10.3390\/ijms21030888","volume":"21","author":"A Ellert-Miklaszewska","year":"2020","unstructured":"Ellert-Miklaszewska A, Poleszak K, Pasierbinska M, Kaminska B. Integrin Signaling in Glioma Pathogenesis: From Biology to Therapy. Int J Mol Sci. 2020;21:888. https:\/\/doi.org\/10.3390\/ijms21030888.","journal-title":"Int J Mol Sci"},{"key":"816_CR81","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s11523-010-0156-3","volume":"5","author":"G Tabatabai","year":"2010","unstructured":"Tabatabai G, Weller M, Nabors B, Picard M, Reardon D, Mikkelsen T, et al. Targeting integrins in malignant glioma. Target Oncol. 2010;5:175\u201381. https:\/\/doi.org\/10.1007\/s11523-010-0156-3.","journal-title":"Target Oncol"},{"key":"816_CR82","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/jebm.12434","volume":"14","author":"J-Q Wang","year":"2021","unstructured":"Wang J-Q, Wu Z-X, Yang Y, Teng Q-X, Li Y-D, Lei Z-N, et al. ATP-binding cassette (ABC) transporters in cancer: A review of recent updates. J Evid Based Med. 2021;14:232\u201356. https:\/\/doi.org\/10.1111\/jebm.12434.","journal-title":"J Evid Based Med"},{"key":"816_CR83","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00018-022-04432-w","volume":"79","author":"ME Eng","year":"2022","unstructured":"Eng ME, Imperio GE, Bloise E, Matthews SG. ATP-binding cassette (ABC) drug transporters in the developing blood-brain barrier: role in fetal brain protection. Cell Mol Life Sci. 2022;79:415. https:\/\/doi.org\/10.1007\/s00018-022-04432-w.","journal-title":"Cell Mol Life Sci"},{"key":"816_CR84","doi-asserted-by":"publisher","first-page":"625","DOI":"10.2174\/1389200211314060001","volume":"14","author":"ML Pinz\u00f3n-Daza","year":"2013","unstructured":"Pinz\u00f3n-Daza ML, Campia I, Kopecka J, Garz\u00f3n R, Ghigo D, Riganti C. Nanoparticle- and liposome-carried drugs: new strategies for active targeting and drug delivery across blood-brain barrier. Curr Drug Metab. 2013;14:625\u201340. https:\/\/doi.org\/10.2174\/1389200211314060001.","journal-title":"Curr Drug Metab"},{"key":"816_CR85","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.3390\/pharmaceutics15051563","volume":"15","author":"W Zhang","year":"2023","unstructured":"Zhang W, Liu QY, Haqqani AS, Liu Z, Sodja C, Leclerc S, et al. Differential Expression of ABC Transporter Genes in Brain Vessels vs. Peripheral Tissues and Vessels from Human, Mouse and Rat. Pharmaceutics. 2023;15:1563. https:\/\/doi.org\/10.3390\/pharmaceutics15051563.","journal-title":"Pharmaceutics"},{"key":"816_CR86","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.phrs.2009.02.007","volume":"59","author":"MS Warren","year":"2009","unstructured":"Warren MS, Zerangue N, Woodford K, Roberts LM, Tate EH, Feng B, et al. Comparative gene expression profiles of ABC transporters in brain microvessel endothelial cells and brain in five species including human. Pharmacol Res. 2009;59:404\u201313. https:\/\/doi.org\/10.1016\/j.phrs.2009.02.007.","journal-title":"Pharmacol Res"},{"key":"816_CR87","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1038\/jcbfm.2012.1","volume":"32","author":"RN Gunn","year":"2012","unstructured":"Gunn RN, Summerfield SG, Salinas CA, Read KD, Guo Q, Searle GE, et al. Combining PET biodistribution and equilibrium dialysis assays to assess the free brain concentration and BBB transport of CNS drugs. J Cereb Blood Flow Metab. 2012;32:874\u201383. https:\/\/doi.org\/10.1038\/jcbfm.2012.1.","journal-title":"J Cereb Blood Flow Metab"},{"key":"816_CR88","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/164_2020_403","volume":"273","author":"HCC Helms","year":"2022","unstructured":"Helms HCC, Kristensen M, Saaby L, Fricker G, Brodin B. Drug Delivery Strategies to Overcome the Blood-Brain Barrier (BBB). Handb Exp Pharmacol. 2022;273:151\u201383. https:\/\/doi.org\/10.1007\/164_2020_403.","journal-title":"Handb Exp Pharmacol"},{"key":"816_CR89","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1248\/bpb.b21-00408","volume":"44","author":"Y Hashimoto","year":"2021","unstructured":"Hashimoto Y, Campbell M, Tachibana K, Okada Y, Kondoh M. Claudin-5: A Pharmacological Target to Modify the Permeability of the Blood-Brain Barrier. Biol Pharm Bull. 2021;44:1380\u201390. https:\/\/doi.org\/10.1248\/bpb.b21-00408.","journal-title":"Biol Pharm Bull"},{"key":"816_CR90","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.copbio.2020.06.009","volume":"66","author":"CS Lee","year":"2020","unstructured":"Lee CS, Leong KW. Advances in microphysiological blood-brain barrier (BBB) models towards drug delivery. Curr Opin Biotechnol. 2020;66:78\u201387. https:\/\/doi.org\/10.1016\/j.copbio.2020.06.009.","journal-title":"Curr Opin Biotechnol"},{"key":"816_CR91","doi-asserted-by":"publisher","first-page":"4734","DOI":"10.7150\/thno.69682","volume":"12","author":"DH Upton","year":"2022","unstructured":"Upton DH, Ung C, George SM, Tsoli M, Kavallaris M, Ziegler DS. Challenges and opportunities to penetrate the blood-brain barrier for brain cancer therapy. Theranostics. 2022;12:4734\u201352. https:\/\/doi.org\/10.7150\/thno.69682.","journal-title":"Theranostics"},{"key":"816_CR92","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/s41419-019-1771-2","volume":"10","author":"P Wu","year":"2019","unstructured":"Wu P, Gao Y, Shen S, Xue Y, Liu X, Ruan X, et al. KHDRBS3 regulates the permeability of blood-tumor barrier via cDENND4C\/miR-577 axis. Cell Death Dis. 2019;10:536. https:\/\/doi.org\/10.1038\/s41419-019-1771-2.","journal-title":"Cell Death Dis"},{"key":"816_CR93","doi-asserted-by":"publisher","first-page":"130642","DOI":"10.1016\/j.ijbiomac.2024.130642","volume":"265","author":"C Liang","year":"2024","unstructured":"Liang C, Zhai B, Wei D, Niu B, Ma J, Yao Y, et al. FXR1 stabilizes SNORD63 to regulate blood-tumor barrier permeability through SNORD63 mediated 2\u2019-O-methylation of POU6F1. Int J Biol Macromol. 2024;265:130642. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.130642.","journal-title":"Int J Biol Macromol"},{"key":"816_CR94","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.3390\/pharmaceutics12121205","volume":"12","author":"JI Griffith","year":"2020","unstructured":"Griffith JI, Rathi S, Zhang W, Zhang W, Drewes LR, Sarkaria JN, et al. Addressing BBB Heterogeneity: A New Paradigm for Drug Delivery to Brain Tumors. Pharmaceutics. 2020;12:1205. https:\/\/doi.org\/10.3390\/pharmaceutics12121205.","journal-title":"Pharmaceutics"},{"key":"816_CR95","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.semcancer.2020.04.001","volume":"69","author":"FH Pottoo","year":"2021","unstructured":"Pottoo FH, Javed MN, Rahman JU, Abu-Izneid T, Khan FA. Targeted delivery of miRNA based therapeuticals in the clinical management of Glioblastoma Multiforme. Semin Cancer Biol. 2021;69:391\u20138. https:\/\/doi.org\/10.1016\/j.semcancer.2020.04.001.","journal-title":"Semin Cancer Biol"},{"key":"816_CR96","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.jconrel.2022.03.047","volume":"345","author":"S Wu","year":"2022","unstructured":"Wu S, Lu L, Zhou J, Ran D, Wang S, Xu Q, et al. All-stage targeted therapy for glioblastoma based on lipid membrane coated cabazitaxel nanocrystals. J Control Release. 2022;345:685\u201395. https:\/\/doi.org\/10.1016\/j.jconrel.2022.03.047.","journal-title":"J Control Release"},{"key":"816_CR97","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1017\/S1462399411001888","volume":"13","author":"S Agarwal","year":"2011","unstructured":"Agarwal S, Sane R, Oberoi R, Ohlfest JR, Elmquist WF. Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain. Expert Rev Mol Med. 2011;13:e17. https:\/\/doi.org\/10.1017\/S1462399411001888.","journal-title":"Expert Rev Mol Med"},{"key":"816_CR98","doi-asserted-by":"publisher","first-page":"000954","DOI":"10.12890\/2018_000954","volume":"5","author":"W Al-Janabi","year":"2018","unstructured":"Al-Janabi W, Krebs R, Arcila-Londono X, Zaman I, Ahmad BK. Atypical Presentation of Glioblastoma Multiforme. Eur J Case Rep Intern Med. 2018;5:000954. https:\/\/doi.org\/10.12890\/2018_000954.","journal-title":"Eur J Case Rep Intern Med"},{"key":"816_CR99","doi-asserted-by":"publisher","first-page":"1584688","DOI":"10.3389\/fphar.2025.1584688","volume":"16","author":"M Fu","year":"2025","unstructured":"Fu M, Xue B, Miao X, Gao Z. Overcoming immunotherapy resistance in glioblastoma: challenges and emerging strategies. Front Pharmacol. 2025;16:1584688. https:\/\/doi.org\/10.3389\/fphar.2025.1584688.","journal-title":"Front Pharmacol"},{"key":"816_CR100","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3322\/caac.21613","volume":"70","author":"AC Tan","year":"2020","unstructured":"Tan AC, Ashley DM, L\u00f3pez GY, Malinzak M, Friedman HS, Khasraw M. Management of glioblastoma: State of the art and future directions. CA Cancer J Clin. 2020;70:299\u2013312. https:\/\/doi.org\/10.3322\/caac.21613.","journal-title":"CA Cancer J Clin"},{"key":"816_CR101","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1111\/cas.15773","volume":"114","author":"H Wu","year":"2023","unstructured":"Wu H, Guo C, Wang C, Xu J, Zheng S, Duan J, et al. Single-cell RNA sequencing reveals tumor heterogeneity, microenvironment, and drug-resistance mechanisms of recurrent glioblastoma. Cancer Sci. 2023;114:2609\u201321. https:\/\/doi.org\/10.1111\/cas.15773.","journal-title":"Cancer Sci"},{"key":"816_CR102","doi-asserted-by":"publisher","first-page":"3811","DOI":"10.1038\/s41467-020-17512-x","volume":"11","author":"W Zhou","year":"2020","unstructured":"Zhou W, Yao Y, Scott AJ, Wilder-Romans K, Dresser JJ, Werner CK, et al. Purine metabolism regulates DNA repair and therapy resistance in glioblastoma. Nat Commun. 2020;11:3811. https:\/\/doi.org\/10.1038\/s41467-020-17512-x.","journal-title":"Nat Commun"},{"key":"816_CR103","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3390\/cells10030484","volume":"10","author":"A Goenka","year":"2021","unstructured":"Goenka A, Tiek D, Song X, Huang T, Hu B, Cheng S-Y. The Many Facets of Therapy Resistance and Tumor Recurrence in Glioblastoma. Cells. 2021;10:484. https:\/\/doi.org\/10.3390\/cells10030484.","journal-title":"Cells"},{"key":"816_CR104","doi-asserted-by":"publisher","first-page":"18002","DOI":"10.1038\/s41598-018-36280-9","volume":"8","author":"JJ Parker","year":"2018","unstructured":"Parker JJ, Canoll P, Niswander L, Kleinschmidt-DeMasters BK, Foshay K, Waziri A. Intratumoral heterogeneity of endogenous tumor cell invasive behavior in human glioblastoma. Sci Rep. 2018;8:18002. https:\/\/doi.org\/10.1038\/s41598-018-36280-9.","journal-title":"Sci Rep"},{"key":"816_CR105","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.3390\/ijms19102879","volume":"19","author":"M Da Ros","year":"2018","unstructured":"Da Ros M, De Gregorio V, Iorio AL, Giunti L, Guidi M, de Martino M, et al. Glioblastoma Chemoresistance: The Double Play by Microenvironment and Blood-Brain Barrier. Int J Mol Sci. 2018;19:2879. https:\/\/doi.org\/10.3390\/ijms19102879.","journal-title":"Int J Mol Sci"},{"key":"816_CR106","doi-asserted-by":"publisher","first-page":"37437","DOI":"10.1038\/s41598-025-21272-3","volume":"15","author":"FS Sica","year":"2025","unstructured":"Sica FS, Patrucco M, Giambra M, Ghizzi M, Sesana S, Vergani B, et al. Modulation of the blood-brain barrier permeability by patient-derived glioblastoma stem cell secretome. Sci Rep. 2025;15:37437. https:\/\/doi.org\/10.1038\/s41598-025-21272-3.","journal-title":"Sci Rep"},{"key":"816_CR107","doi-asserted-by":"publisher","unstructured":"Lam MS, Aw JJ, Tan D, Vijayakumar R, Lim HYG, Yada S, et al. Unveiling the influence of tumor microenvironment and spatial heterogeneity on temozolomide resistance in glioblastoma using an advanced human in vitro model of the blood-brain barrier and glioblastoma. Small. Weinheim an der Bergstrasse, Germany; 2023;19:e2302280. https:\/\/doi.org\/10.1002\/smll.202302280.","DOI":"10.1002\/smll.202302280"},{"key":"816_CR108","doi-asserted-by":"publisher","first-page":"216078","DOI":"10.1016\/j.canlet.2023.216078","volume":"557","author":"J Li","year":"2023","unstructured":"Li J, Song C, Gu J, Li C, Zang W, Shi L, et al. RBBP4 regulates the expression of the Mre11-Rad50-NBS1 (MRN) complex and promotes DNA double-strand break repair to mediate glioblastoma chemoradiotherapy resistance. Cancer Lett. 2023;557:216078. https:\/\/doi.org\/10.1016\/j.canlet.2023.216078.","journal-title":"Cancer Lett"},{"key":"816_CR109","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1038\/s41467-018-05373-4","volume":"9","author":"X Chen","year":"2018","unstructured":"Chen X, Zhang M, Gan H, Wang H, Lee J-H, Fang D, et al. A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma. Nat Commun. 2018;9:2949. https:\/\/doi.org\/10.1038\/s41467-018-05373-4.","journal-title":"Nat Commun"},{"key":"816_CR110","doi-asserted-by":"publisher","first-page":"26224","DOI":"10.1038\/s41598-024-77348-z","volume":"14","author":"T Lan","year":"2024","unstructured":"Lan T, Quan W, Yu D-H, Chen X, Wang Z-F, Li Z-Q. High expression of LncRNA HOTAIR is a risk factor for temozolomide resistance in glioblastoma via activation of the miR-214\/\u03b2-catenin\/MGMT pathway. Sci Rep. 2024;14:26224. https:\/\/doi.org\/10.1038\/s41598-024-77348-z.","journal-title":"Sci Rep"},{"key":"816_CR111","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1038\/nn.4584","volume":"20","author":"G Guo","year":"2017","unstructured":"Guo G, Gong K, Ali S, Ali N, Shallwani S, Hatanpaa KJ, et al. A TNF-JNK-Axl-ERK signaling axis mediates primary resistance to EGFR inhibition in glioblastoma. Nat Neurosci. 2017;20:1074\u201384. https:\/\/doi.org\/10.1038\/nn.4584.","journal-title":"Nat Neurosci"},{"key":"816_CR112","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1038\/s41388-020-1208-5","volume":"39","author":"N Struve","year":"2020","unstructured":"Struve N, Binder ZA, Stead LF, Brend T, Bagley SJ, Faulkner C, et al. EGFRvIII upregulates DNA mismatch repair resulting in increased temozolomide sensitivity of MGMT promoter methylated glioblastoma. Oncogene. 2020;39:3041\u201355. https:\/\/doi.org\/10.1038\/s41388-020-1208-5.","journal-title":"Oncogene"},{"key":"816_CR113","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41419-025-07771-1","volume":"16","author":"F Yuan","year":"2025","unstructured":"Yuan F, Wang Y, Yuan L, Tang T, Ye L, Li Y, et al. EGFRvIII-positive glioblastoma contributes to immune escape and malignant progression via the c-Fos-MDK-LRP1 axis. Cell Death Dis. 2025;16:453. https:\/\/doi.org\/10.1038\/s41419-025-07771-1.","journal-title":"Cell Death Dis"},{"key":"816_CR114","doi-asserted-by":"publisher","first-page":"5294","DOI":"10.1038\/s41467-024-49316-8","volume":"15","author":"DJ Laverty","year":"2024","unstructured":"Laverty DJ, Gupta SK, Bradshaw GA, Hunter AS, Carlson BL, Calmo NM, et al. ATM inhibition exploits checkpoint defects and ATM-dependent double strand break repair in TP53-mutant glioblastoma. Nat Commun. 2024;15:5294. https:\/\/doi.org\/10.1038\/s41467-024-49316-8.","journal-title":"Nat Commun"},{"key":"816_CR115","doi-asserted-by":"publisher","first-page":"15223","DOI":"10.1038\/ncomms15223","volume":"8","author":"JA Benitez","year":"2017","unstructured":"Benitez JA, Ma J, D\u2019Antonio M, Boyer A, Camargo MF, Zanca C, et al. PTEN regulates glioblastoma oncogenesis through chromatin-associated complexes of DAXX and histone H3.3. Nat Commun. 2017;8:15223. https:\/\/doi.org\/10.1038\/ncomms15223.","journal-title":"Nat Commun"},{"key":"816_CR116","doi-asserted-by":"publisher","first-page":"5907","DOI":"10.3390\/ijms22115907","volume":"22","author":"C-Y Tsai","year":"2021","unstructured":"Tsai C-Y, Ko H-J, Chiou S-J, Lai Y-L, Hou C-C, Javaria T, et al. NBM-BMX, an HDAC8 Inhibitor, Overcomes Temozolomide Resistance in Glioblastoma Multiforme by Downregulating the \u03b2-Catenin\/c-Myc\/SOX2 Pathway and Upregulating p53-Mediated MGMT Inhibition. Int J Mol Sci. 2021;22:5907. https:\/\/doi.org\/10.3390\/ijms22115907.","journal-title":"Int J Mol Sci"},{"issue":"25","key":"816_CR117","doi-asserted-by":"publisher","first-page":"00351","DOI":"10.1016\/j.jare.2025.05.032","volume":"S2090\u20131232","author":"W Gao","year":"2025","unstructured":"Gao W, Long X, Lin X, Deng K, Li D, Huang M, et al. Targeting mesenchymal monocyte-derived macrophages to enhance the sensitivity of glioblastoma to temozolomide by inhibiting TNF\/CELSR2\/p65\/Kla-HDAC1\/EPAS1 axis. J Adv Res. 2025;S2090\u20131232(25):00351\u20130. https:\/\/doi.org\/10.1016\/j.jare.2025.05.032.","journal-title":"J Adv Res"},{"key":"816_CR118","doi-asserted-by":"publisher","first-page":"152372","DOI":"10.1016\/j.seminoncol.2025.152372","volume":"52","author":"EY Theab","year":"2025","unstructured":"Theab EY, Alkhathami AG, Ridha Ali I, Al-Hetty HRAK, Ballal S, Kalia R, et al. Exosomal circular RNAs as drivers of temozolomide resistance in glioblastoma: Mechanisms and implications. Semin Oncol. 2025;52:152372. https:\/\/doi.org\/10.1016\/j.seminoncol.2025.152372.","journal-title":"Semin Oncol"},{"key":"816_CR119","doi-asserted-by":"publisher","first-page":"116533","DOI":"10.1016\/j.bmc.2021.116533","volume":"53","author":"Y He","year":"2022","unstructured":"He Y, Yang C, Wang Y, Sacher JR, Sims MM, Pfeffer LM, et al. Novel structural-related analogs of PFI-3 (SRAPs) that target the BRG1 catalytic subunit of the SWI\/SNF complex increase the activity of temozolomide in glioblastoma cells. Bioorg Med Chem. 2022;53:116533. https:\/\/doi.org\/10.1016\/j.bmc.2021.116533.","journal-title":"Bioorg Med Chem"},{"key":"816_CR120","doi-asserted-by":"publisher","first-page":"118782","DOI":"10.1016\/j.bbamcr.2020.118782","volume":"1867","author":"B Majc","year":"2020","unstructured":"Majc B, Sever T, Zari\u0107 M, Breznik B, Turk B, Lah TT. Epithelial-to-mesenchymal transition as the driver of changing carcinoma and glioblastoma microenvironment. Biochim Biophys Acta Mol Cell Res. 2020;1867:118782. https:\/\/doi.org\/10.1016\/j.bbamcr.2020.118782.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"816_CR121","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1038\/s41598-020-59462-w","volume":"10","author":"W Pu","year":"2020","unstructured":"Pu W, Qiu J, Riggins GJ, Parat M-O. Matrix protease production, epithelial-to-mesenchymal transition marker expression and invasion of glioblastoma cells in response to osmotic or hydrostatic pressure. Sci Rep. 2020;10:2634. https:\/\/doi.org\/10.1038\/s41598-020-59462-w.","journal-title":"Sci Rep"},{"key":"816_CR122","doi-asserted-by":"publisher","first-page":"101606","DOI":"10.1016\/j.mtbio.2025.101606","volume":"31","author":"Q Zhao","year":"2025","unstructured":"Zhao Q, Li Y, Sun Q, Wang R, Lu H, Zhang X, et al. Self-assembled genistein nanoparticles suppress the epithelial-mesenchymal transition in glioblastoma by targeting MMP9. Mater Today Bio. 2025;31:101606. https:\/\/doi.org\/10.1016\/j.mtbio.2025.101606.","journal-title":"Mater Today Bio"},{"key":"816_CR123","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41419-024-06904-2","volume":"15","author":"J Bou-Gharios","year":"2024","unstructured":"Bou-Gharios J, No\u00ebl G, Burckel H. Preclinical and clinical advances to overcome hypoxia in glioblastoma multiforme. Cell Death Dis. 2024;15:503. https:\/\/doi.org\/10.1038\/s41419-024-06904-2.","journal-title":"Cell Death Dis"},{"key":"816_CR124","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00018-020-03483-1","volume":"78","author":"B Zhang","year":"2021","unstructured":"Zhang B, Chen Y, Shi X, Zhou M, Bao L, Hatanpaa KJ, et al. Regulation of branched-chain amino acid metabolism by hypoxia-inducible factor in glioblastoma. Cell Mol Life Sci. 2021;78:195\u2013206. https:\/\/doi.org\/10.1007\/s00018-020-03483-1.","journal-title":"Cell Mol Life Sci"},{"key":"816_CR125","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s40164-024-00519-1","volume":"13","author":"Z Shi","year":"2024","unstructured":"Shi Z, Hu C, Zheng X, Sun C, Li Q. Feedback loop between hypoxia and energy metabolic reprogramming aggravates the radioresistance of cancer cells. Exp Hematol Oncol. 2024;13:55. https:\/\/doi.org\/10.1186\/s40164-024-00519-1.","journal-title":"Exp Hematol Oncol"},{"key":"816_CR126","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.wneu.2015.12.032","volume":"88","author":"M Karsy","year":"2016","unstructured":"Karsy M, Guan J, Jensen R, Huang LE, Colman H. The Impact of Hypoxia and Mesenchymal Transition on Glioblastoma Pathogenesis and Cancer Stem Cells Regulation. World Neurosurg. 2016;88:222\u201336. https:\/\/doi.org\/10.1016\/j.wneu.2015.12.032.","journal-title":"World Neurosurg"},{"key":"816_CR127","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1093\/neuonc\/nos195","volume":"14","author":"C-W Chou","year":"2012","unstructured":"Chou C-W, Wang C-C, Wu C-P, Lin Y-J, Lee Y-C, Cheng Y-W, et al. Tumor cycling hypoxia induces chemoresistance in glioblastoma multiforme by upregulating the expression and function of ABCB1. Neuro Oncol. 2012;14:1227\u201338. https:\/\/doi.org\/10.1093\/neuonc\/nos195.","journal-title":"Neuro Oncol"},{"key":"816_CR128","doi-asserted-by":"publisher","first-page":"1584407","DOI":"10.3389\/fnmol.2025.1584407","volume":"18","author":"S Gong","year":"2025","unstructured":"Gong S, Wang P, Liao B, Zhao L, Wu N. Hyperbaric oxygen promotes both the proliferation and chemosensitization of glioblastoma cells by inhibiting HIF1\u03b1\/HIF2\u03b1-ABCG2. Front Mol Neurosci. 2025;18:1584407. https:\/\/doi.org\/10.3389\/fnmol.2025.1584407.","journal-title":"Front Mol Neurosci"},{"key":"816_CR129","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.33594\/000000311","volume":"54","author":"C Zolotoff","year":"2020","unstructured":"Zolotoff C, Voirin A-C, Puech C, Roche F, Perek N. Intermittent Hypoxia and Its Impact on Nrf2\/HIF-1\u03b1 Expression and ABC Transporters: An in Vitro Human Blood-Brain Barrier Model Study. Cell Physiol Biochem. 2020;54:1231\u201348. https:\/\/doi.org\/10.33594\/000000311.","journal-title":"Cell Physiol Biochem"},{"key":"816_CR130","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41419-017-0251-9","volume":"9","author":"X Zhang","year":"2018","unstructured":"Zhang X, Liu X, Zhou W, Yang M, Ding Y, Wang Q, et al. Fasudil increases temozolomide sensitivity and suppresses temozolomide-resistant glioma growth via inhibiting ROCK2\/ABCG2. Cell Death Dis. 2018;9:190. https:\/\/doi.org\/10.1038\/s41419-017-0251-9.","journal-title":"Cell Death Dis"},{"key":"816_CR131","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1158\/1535-7163.MCT-25-0019","volume":"24","author":"B Koltun","year":"2025","unstructured":"Koltun B, Voloshin T, David C, Kan T, Barsheshet Y, Volodin A, et al. Cancer Cell Permeability Induced by Tumor Treating Fields (TTFields) as a Physical Approach to Improve Chemotherapy Uptake and Overcome Multidrug Resistance. Mol Cancer Ther. 2025;24:1815\u201325. https:\/\/doi.org\/10.1158\/1535-7163.MCT-25-0019.","journal-title":"Mol Cancer Ther"},{"key":"816_CR132","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1093\/neuonc\/noae207","volume":"27","author":"Y Huang","year":"2025","unstructured":"Huang Y, Shan Y, Zhang W, Printzis C, Pesce L, Stover D, et al. Sex differences in the molecular profile of adult diffuse glioma are shaped by IDH status and tumor microenvironment. Neuro Oncol. 2025;27:430\u201344. https:\/\/doi.org\/10.1093\/neuonc\/noae207.","journal-title":"Neuro Oncol"},{"key":"816_CR133","doi-asserted-by":"publisher","first-page":"111801","DOI":"10.1016\/j.mad.2023.111801","volume":"211","author":"A Colopi","year":"2023","unstructured":"Colopi A, Fuda S, Santi S, Onorato A, Cesarini V, Salvati M, et al. Impact of age and gender on glioblastoma onset, progression, and management. Mech Ageing Dev. 2023;211:111801. https:\/\/doi.org\/10.1016\/j.mad.2023.111801.","journal-title":"Mech Ageing Dev"},{"key":"816_CR134","doi-asserted-by":"publisher","DOI":"10.1101\/2025.05.16.654616","author":"TJ Abou-Antoun","year":"2025","unstructured":"Abou-Antoun TJ, Llaci L, Wong JP, Yang L, Warrington NM, Tripp L, et al. EGR1 drives sex-differences in glioblastoma tumorigenicity. bioRxiv. 2025. https:\/\/doi.org\/10.1101\/2025.05.16.654616. 2025.05.16.654616.","journal-title":"bioRxiv"},{"key":"816_CR135","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1158\/2159-8290.CD-22-0869","volume":"13","author":"J Lee","year":"2023","unstructured":"Lee J, Nicosia M, Hong ES, Silver DJ, Li C, Bayik D, et al. Sex-Biased T-cell Exhaustion Drives Differential Immune Responses in Glioblastoma. Cancer Discov. 2023;13:2090\u2013105. https:\/\/doi.org\/10.1158\/2159-8290.CD-22-0869.","journal-title":"Cancer Discov"},{"key":"816_CR136","doi-asserted-by":"publisher","DOI":"10.1101\/2024.06.06.597433","author":"ME Tharp","year":"2025","unstructured":"Tharp ME, Han CZ, Talukdar M, Balak CD, Fitzpatrick C, Connor CO, et al. The inactive X chromosome drives sex differences in microglial inflammatory activity in human glioblastoma. bioRxiv. 2025. https:\/\/doi.org\/10.1101\/2024.06.06.597433. 2024.06.06.597433.","journal-title":"bioRxiv"},{"key":"816_CR137","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.3390\/cells10071783","volume":"10","author":"A Carrano","year":"2021","unstructured":"Carrano A, Juarez JJ, Incontri D, Ibarra A, Guerrero Cazares H. Sex-Specific Differences in Glioblastoma. Cells. 2021;10:1783. https:\/\/doi.org\/10.3390\/cells10071783.","journal-title":"Cells"},{"key":"816_CR138","doi-asserted-by":"publisher","first-page":"vdaf017","DOI":"10.1093\/noajnl\/vdaf017","volume":"7","author":"OR Alem\u00e1n","year":"2025","unstructured":"Alem\u00e1n OR, Quintero JC, Camacho-Arroyo I. The language of glioblastoma: A tale of cytokines and sex hormones communication. Neurooncol Adv. 2025;7:vdaf017. https:\/\/doi.org\/10.1093\/noajnl\/vdaf017.","journal-title":"Neurooncol Adv"},{"key":"816_CR139","doi-asserted-by":"publisher","DOI":"10.1101\/2025.08.06.668464","author":"AR Sloan","year":"2026","unstructured":"Sloan AR, Bukenya G, Tannish GP, Silver DJ, Aggarwal A, Lee J, et al. Platelets regulate glioblastoma growth and immunity via sex-dependent PAR4 - Estrogen receptor beta signaling. bioRxiv. 2026. https:\/\/doi.org\/10.1101\/2025.08.06.668464. 2025.08.06.668464.","journal-title":"bioRxiv"},{"key":"816_CR140","doi-asserted-by":"publisher","first-page":"vdaf250","DOI":"10.1093\/noajnl\/vdaf250","volume":"8","author":"V Nakhate","year":"2026","unstructured":"Nakhate V, Westergaard C, Lan Z, Lasica AB, Muzikansky A, Barlow B, et al. Evaluation of sex differences in survival among glioblastoma patients treated with immune checkpoint inhibitors. Neurooncol Adv. 2026;8:vdaf250. https:\/\/doi.org\/10.1093\/noajnl\/vdaf250.","journal-title":"Neurooncol Adv"},{"key":"816_CR141","doi-asserted-by":"publisher","first-page":"3486","DOI":"10.3390\/cancers17213486","volume":"17","author":"O Padilla","year":"2025","unstructured":"Padilla O, Tazhibi M, McQuillan N, Buss EJ, Sisti MB, Bruce JN, et al. Sex-Based Differences in Outcomes for Glioblastoma Patients Treated with Hypofractionated Chemoradiotherapy. Cancers (Basel). 2025;17:3486. https:\/\/doi.org\/10.3390\/cancers17213486.","journal-title":"Cancers (Basel)"},{"key":"816_CR142","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13293-025-00751-2","volume":"16","author":"X Mi","year":"2025","unstructured":"Mi X, Ye Z-L, Zhang X-J, Chen X-C, Dai X-M. Sex- and age- differences in the expression of critical blood-brain barrier regulators: a physiological context. Biol Sex Differ. 2025;16:67. https:\/\/doi.org\/10.1186\/s13293-025-00751-2.","journal-title":"Biol Sex Differ"},{"key":"816_CR143","doi-asserted-by":"publisher","first-page":"115325","DOI":"10.1016\/j.expneurol.2025.115325","volume":"392","author":"GV Velmurugan","year":"2025","unstructured":"Velmurugan GV, Prajapati S, Tran S, Miller C, Burke B, Hubbard WB. Sex-dependent blood-brain barrier alterations following repeated mild blast traumatic brain injury at varying inter-injury intervals. Exp Neurol. 2025;392:115325. https:\/\/doi.org\/10.1016\/j.expneurol.2025.115325.","journal-title":"Exp Neurol"},{"key":"816_CR144","doi-asserted-by":"publisher","first-page":"e70196","DOI":"10.1111\/cts.70196","volume":"18","author":"G Salvi de Souza","year":"2025","unstructured":"Salvi de Souza G, Liu W, Mossel P, Somsen JF, Bartels AL, Furini CRG, et al. Exploratory Study of Sex Differences in P-Glycoprotein Function at the Blood-Brain Barrier. Clin Transl Sci. 2025;18:e70196. https:\/\/doi.org\/10.1111\/cts.70196.","journal-title":"Clin Transl Sci"},{"key":"816_CR145","doi-asserted-by":"publisher","first-page":"bqae081","DOI":"10.1210\/endocr\/bqae081","volume":"165","author":"DB Banks","year":"2024","unstructured":"Banks DB, Lierz SL, Cannon RE, Korach KS. Nongenomic ER\u03b1-AMPK Signaling Regulates Sex-Dependent Bcrp Transport Activity at the Blood-Brain Barrier. Endocrinology. 2024;165:bqae081. https:\/\/doi.org\/10.1210\/endocr\/bqae081.","journal-title":"Endocrinology"},{"key":"816_CR146","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12987-023-00496-3","volume":"21","author":"A Collignon","year":"2024","unstructured":"Collignon A, Dion-Albert L, M\u00e9nard C, Coelho-Santos V. Sex, hormones and cerebrovascular function: from development to disorder. Fluids Barriers CNS. 2024;21:2. https:\/\/doi.org\/10.1186\/s12987-023-00496-3.","journal-title":"Fluids Barriers CNS"},{"key":"816_CR147","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12987-024-00562-4","volume":"21","author":"A Lentzas","year":"2024","unstructured":"Lentzas A, de Gooijer MC, Zuidema S, Meurs A, \u00c7itirikkaya CH, Venekamp N, et al. ATP-binding cassette transporter inhibitor potency and substrate drug affinity are critical determinants of successful drug delivery enhancement to the brain. Fluids Barriers CNS. 2024;21:62. https:\/\/doi.org\/10.1186\/s12987-024-00562-4.","journal-title":"Fluids Barriers CNS"},{"key":"816_CR148","doi-asserted-by":"publisher","first-page":"e30277","DOI":"10.7759\/cureus.30277","volume":"14","author":"DR Hallan","year":"2022","unstructured":"Hallan DR, Tankam CS, Harbaugh T, Rizk E. Risk of Glioblastoma Multiforme in Patients Taking Ion Channel Blockers. Cureus. 2022;14:e30277. https:\/\/doi.org\/10.7759\/cureus.30277.","journal-title":"Cureus"},{"key":"816_CR149","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3390\/curroncol32040185","volume":"32","author":"J Rousseau","year":"2025","unstructured":"Rousseau J, Lapointe S, Roberge D. Tumor-Treating Fields and Related Treatments in the Management of Pediatric Brain Tumors. Curr Oncol. 2025;32:185. https:\/\/doi.org\/10.3390\/curroncol32040185.","journal-title":"Curr Oncol"},{"key":"816_CR150","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2478\/raon-2023-0044","volume":"57","author":"X Li","year":"2023","unstructured":"Li X, Liu K, Xing L, Rubinsky B. A review of tumor treating fields (TTFields): advancements in clinical applications and mechanistic insights. Radiol Oncol. 2023;57:279\u201391. https:\/\/doi.org\/10.2478\/raon-2023-0044.","journal-title":"Radiol Oncol"},{"key":"816_CR151","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1093\/neuonc\/noae087","volume":"26","author":"K Piper","year":"2024","unstructured":"Piper K, Kumar JI, Domino J, Tuchek C, Vogelbaum MA. Consensus review on strategies to improve delivery across the blood-brain barrier including focused ultrasound. Neuro Oncol. 2024;26:1545\u201356. https:\/\/doi.org\/10.1093\/neuonc\/noae087.","journal-title":"Neuro Oncol"},{"key":"816_CR152","doi-asserted-by":"publisher","first-page":"e4920","DOI":"10.21769\/BioProtoc.4920","volume":"14","author":"Q Cai","year":"2024","unstructured":"Cai Q, Fan H, Li X, Giannotta M, Bachoo R, Qin Z. Optical Modulation of the Blood-Brain Barrier for Glioblastoma Treatment. Bio Protoc. 2024;14:e4920. https:\/\/doi.org\/10.21769\/BioProtoc.4920.","journal-title":"Bio Protoc"},{"key":"816_CR153","first-page":"363","volume":"11","author":"RA Towner","year":"2021","unstructured":"Towner RA, Saunders D, Lerner M, Silasi Mansat R, Yuan T, Barber D, et al. Temporary opening of the blood-brain barrier with the nitrone compound OKN-007. Am J Nucl Med Mol Imaging. 2021;11:363\u201373.","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"816_CR154","doi-asserted-by":"publisher","first-page":"4831","DOI":"10.1038\/s41598-024-55442-6","volume":"14","author":"S-MP Fletcher","year":"2024","unstructured":"Fletcher S-MP, Chisholm A, Lavelle M, Guthier R, Zhang Y, Power C, et al. A study combining microbubble-mediated focused ultrasound and radiation therapy in the healthy rat brain and a F98 glioma model. Sci Rep. 2024;14:4831. https:\/\/doi.org\/10.1038\/s41598-024-55442-6.","journal-title":"Sci Rep"},{"key":"816_CR155","doi-asserted-by":"publisher","unstructured":"Khan I, Kumar D, Zhang W, Difilippantonio S, Robinson C, Wei D, et al. Trastuzumab deruxtecan efficacy, FcRn-facilitated penetration of the blood-tumor barrier and distribution to tumor cells in HER2\u2009+\u2009brain metastasis model systems. Neuro Oncol. 2026;noag002. https:\/\/doi.org\/10.1093\/neuonc\/noag002.","DOI":"10.1093\/neuonc\/noag002"},{"key":"816_CR156","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1158\/1078-0432.CCR-22-1138","volume":"29","author":"S Kabraji","year":"2023","unstructured":"Kabraji S, Ni J, Sammons S, Li T, Van Swearingen AED, Wang Y, et al. Preclinical and Clinical Efficacy of Trastuzumab Deruxtecan in Breast Cancer Brain Metastases. Clin Cancer Res. 2023;29:174\u201382. https:\/\/doi.org\/10.1158\/1078-0432.CCR-22-1138.","journal-title":"Clin Cancer Res"},{"key":"816_CR157","doi-asserted-by":"publisher","first-page":"103083","DOI":"10.1016\/j.ctrv.2025.103083","volume":"143","author":"SW Cheo","year":"2026","unstructured":"Cheo SW, Li MSC, Huang DD-R, Saw SPL, Hendriks LEL, Remon J, et al. Intracranial activity of antibody-drug conjugates in advanced non-small cell lung cancer: What have we accomplished so far? Cancer Treat Rev. 2026;143:103083. https:\/\/doi.org\/10.1016\/j.ctrv.2025.103083.","journal-title":"Cancer Treat Rev"},{"key":"816_CR158","doi-asserted-by":"publisher","first-page":"eaay1163","DOI":"10.1126\/scitranslmed.aay1163","volume":"12","author":"JC Ullman","year":"2020","unstructured":"Ullman JC, Arguello A, Getz JA, Bhalla A, Mahon CS, Wang J, et al. Brain delivery and activity of a lysosomal enzyme using a blood-brain barrier transport vehicle in mice. Sci Transl Med. 2020;12:eaay1163. https:\/\/doi.org\/10.1126\/scitranslmed.aay1163.","journal-title":"Sci Transl Med"},{"key":"816_CR159","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1056\/NEJMoa2508681","volume":"394","author":"J Muenzer","year":"2026","unstructured":"Muenzer J, Burton BK, Harmatz P, Rajan DS, Jones SA, van den Hout JMP, et al. An Intravenous Brain-Penetrant Enzyme Therapy for Mucopolysaccharidosis II. N Engl J Med. 2026;394:39\u201350. https:\/\/doi.org\/10.1056\/NEJMoa2508681.","journal-title":"N Engl J Med"},{"key":"816_CR160","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41392-024-01889-y","volume":"9","author":"B Wang","year":"2024","unstructured":"Wang B, Hu S, Teng Y, Chen J, Wang H, Xu Y, et al. Current advance of nanotechnology in diagnosis and treatment for malignant tumors. Signal Transduct Target Ther. 2024;9:200. https:\/\/doi.org\/10.1038\/s41392-024-01889-y.","journal-title":"Signal Transduct Target Ther"},{"key":"816_CR161","doi-asserted-by":"publisher","first-page":"11990","DOI":"10.1038\/srep11990","volume":"5","author":"X Tian","year":"2015","unstructured":"Tian X, Nyberg S, Sharp S, Madsen P, Daneshpour J, Armes N. LRP-1-mediated intracellular antibody delivery to the Central Nervous System. Sci Rep. 2015;5:11990. https:\/\/doi.org\/10.1038\/srep11990.","journal-title":"Sci Rep"},{"key":"816_CR162","doi-asserted-by":"publisher","first-page":"114904","DOI":"10.1016\/j.colsurfb.2025.114904","volume":"255","author":"A Zuberi","year":"2025","unstructured":"Zuberi A, Rehman U, Gupta G, Ghazwani M, Hani U, Kesharwani P. Smart liposomal systems for brain cancer: Technological innovations in drug delivery. Colloids Surf B Biointerfaces. 2025;255:114904. https:\/\/doi.org\/10.1016\/j.colsurfb.2025.114904.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"816_CR163","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s11060-024-04904-y","volume":"172","author":"KH Narsinh","year":"2025","unstructured":"Narsinh KH, Kumar K, Bankiewicz K, Martin AJ, Berger M, Clarke J, et al. A phase I study of convection-enhanced delivery (CED) of liposomal-irinotecan using real-time magnetic resonance imaging in patients with recurrent high-grade glioma. J Neurooncol. 2025;172:219\u201327. https:\/\/doi.org\/10.1007\/s11060-024-04904-y.","journal-title":"J Neurooncol"},{"key":"816_CR164","doi-asserted-by":"publisher","first-page":"115811","DOI":"10.1016\/j.addr.2026.115811","volume":"232","author":"AH Elati","year":"2026","unstructured":"Elati AH, Davies EW, Mishra MV, Winkles JA, Woodworth GF, Kim AJ. Platinum-based therapeutics as emerging multi-modal radiosensitizers in glioblastoma treatment. Adv Drug Deliv Rev. 2026;232:115811. https:\/\/doi.org\/10.1016\/j.addr.2026.115811.","journal-title":"Adv Drug Deliv Rev"},{"key":"816_CR165","doi-asserted-by":"publisher","first-page":"100365","DOI":"10.1016\/j.esmoop.2021.100365","volume":"7","author":"B Kasenda","year":"2022","unstructured":"Kasenda B, K\u00f6nig D, Manni M, Ritschard R, Duthaler U, Bartoszek E, et al. Targeting immunoliposomes to EGFR-positive glioblastoma. ESMO Open. 2022;7:100365. https:\/\/doi.org\/10.1016\/j.esmoop.2021.100365.","journal-title":"ESMO Open"},{"key":"816_CR166","doi-asserted-by":"publisher","DOI":"10.1101\/2025.03.29.646102","author":"LF Fernandes","year":"2025","unstructured":"Fernandes LF, Peeyatu C, Dickie BR, Ho YS, Thompson LA, Hernandez N, et al. Targeting therapeutic nanoparticles to the glioblastoma resection margin by harnessing post-operative spatiotemporal blood-brain barrier disruption. bioRxiv. 2025. https:\/\/doi.org\/10.1101\/2025.03.29.646102. 2025.03.29.646102.","journal-title":"bioRxiv"},{"key":"816_CR167","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.ejpb.2014.10.017","volume":"88","author":"D Chirio","year":"2014","unstructured":"Chirio D, Gallarate M, Peira E, Battaglia L, Muntoni E, Riganti C, et al. Positive-charged solid lipid nanoparticles as paclitaxel drug delivery system in glioblastoma treatment. Eur J Pharm Biopharm. 2014;88:746\u201358. https:\/\/doi.org\/10.1016\/j.ejpb.2014.10.017.","journal-title":"Eur J Pharm Biopharm"},{"key":"816_CR168","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1002\/jps.24002","volume":"103","author":"L Battaglia","year":"2014","unstructured":"Battaglia L, Gallarate M, Peira E, Chirio D, Muntoni E, Biasibetti E, et al. Solid lipid nanoparticles for potential doxorubicin delivery in glioblastoma treatment: preliminary in vitro studies. J Pharm Sci. 2014;103:2157\u201365. https:\/\/doi.org\/10.1002\/jps.24002.","journal-title":"J Pharm Sci"},{"key":"816_CR169","doi-asserted-by":"publisher","first-page":"639","DOI":"10.2217\/nnm-2016-0380","volume":"12","author":"L Battaglia","year":"2017","unstructured":"Battaglia L, Muntoni E, Chirio D, Peira E, Annovazzi L, Schiffer D, et al. Solid lipid nanoparticles by coacervation loaded with a methotrexate prodrug: preliminary study for glioma treatment. Nanomed (Lond) Lond Engl. 2017;12:639\u201356. https:\/\/doi.org\/10.2217\/nnm-2016-0380.","journal-title":"Nanomed (Lond) Lond Engl"},{"key":"816_CR170","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1021\/acsbiomaterials.0c01639","volume":"7","author":"BT Jung","year":"2021","unstructured":"Jung BT, Jung K, Lim M, Li M, Santos R, Ozawa T, et al. Design of 18 nm Doxorubicin-Loaded 3-Helix Micelles: Cellular Uptake and Cytotoxicity in Patient-Derived GBM6 Cells. ACS Biomater Sci Eng. 2021;7:196\u2013206. https:\/\/doi.org\/10.1021\/acsbiomaterials.0c01639.","journal-title":"ACS Biomater Sci Eng"},{"key":"816_CR171","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/s41565-024-01769-0","volume":"19","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Qin J, Yu D, Liu Y, Song D, Tian K, et al. Polymer-locking fusogenic liposomes for glioblastoma-targeted siRNA delivery and CRISPR-Cas gene editing. Nat Nanotechnol. 2024;19:1869\u201379. https:\/\/doi.org\/10.1038\/s41565-024-01769-0.","journal-title":"Nat Nanotechnol"},{"key":"816_CR172","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.jconrel.2024.09.019","volume":"375","author":"N Rouatbi","year":"2024","unstructured":"Rouatbi N, Walters AA, Costa PM, Qin Y, Liam-Or R, Grant V, et al. RNA lipid nanoparticles as efficient in vivo CRISPR-Cas9 gene editing tool for therapeutic target validation in glioblastoma cancer stem cells. J Control Release. 2024;375:776\u201387. https:\/\/doi.org\/10.1016\/j.jconrel.2024.09.019.","journal-title":"J Control Release"},{"key":"816_CR173","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.jconrel.2024.03.055","volume":"369","author":"Y Ding","year":"2024","unstructured":"Ding Y, Xu Q, Chai Z, Wu S, Xu W, Wang J, et al. All-stage targeted red blood cell membrane-coated docetaxel nanocrystals for glioma treatment. J Control Release. 2024;369:325\u201334. https:\/\/doi.org\/10.1016\/j.jconrel.2024.03.055.","journal-title":"J Control Release"},{"key":"816_CR174","doi-asserted-by":"publisher","first-page":"15251","DOI":"10.1021\/jacs.4c02530","volume":"146","author":"X Fang","year":"2024","unstructured":"Fang X, Gong R, Yang D, Li C, Zhang Y, Wang Y, et al. NIR-II Light-Driven Genetically Engineered Exosome Nanocatalysts for Efficient Phototherapy against Glioblastoma. J Am Chem Soc. 2024;146:15251\u201363. https:\/\/doi.org\/10.1021\/jacs.4c02530.","journal-title":"J Am Chem Soc"},{"key":"816_CR175","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1186\/s12951-021-01153-3","volume":"19","author":"J-Y Wu","year":"2021","unstructured":"Wu J-Y, Li Y-J, Wang J, Hu X-B, Huang S, Luo S, et al. Multifunctional exosome-mimetics for targeted anti-glioblastoma therapy by manipulating protein corona. J Nanobiotechnol. 2021;19:405. https:\/\/doi.org\/10.1186\/s12951-021-01153-3.","journal-title":"J Nanobiotechnol"},{"key":"816_CR176","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/nnano.2017.82","volume":"12","author":"S Osuka","year":"2017","unstructured":"Osuka S, Van Meir EG. Cancer therapy: Neutrophils traffic in cancer nanodrugs. Nat Nanotechnol. 2017;12:616\u20138. https:\/\/doi.org\/10.1038\/nnano.2017.82.","journal-title":"Nat Nanotechnol"},{"key":"816_CR177","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.jconrel.2023.01.025","volume":"354","author":"KM Dave","year":"2023","unstructured":"Dave KM, Stolz DB, Venna VR, Quaicoe VA, Maniskas ME, Reynolds MJ, et al. Mitochondria-containing extracellular vesicles (EV) reduce mouse brain infarct sizes and EV\/HSP27 protect ischemic brain endothelial cultures. J Control Release. 2023;354:368\u201393. https:\/\/doi.org\/10.1016\/j.jconrel.2023.01.025.","journal-title":"J Control Release"},{"key":"816_CR178","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jconrel.2021.08.038","volume":"338","author":"A D\u2019Souza","year":"2021","unstructured":"D\u2019Souza A, Burch A, Dave KM, Sreeram A, Reynolds MJ, Dobbins DX, et al. Microvesicles transfer mitochondria and increase mitochondrial function in brain endothelial cells. J Control Release. 2021;338:505\u201326. https:\/\/doi.org\/10.1016\/j.jconrel.2021.08.038.","journal-title":"J Control Release"},{"key":"816_CR179","doi-asserted-by":"publisher","first-page":"114068","DOI":"10.1016\/j.jconrel.2025.114068","volume":"386","author":"KM Dave","year":"2025","unstructured":"Dave KM, Pinky PP, Manickam S. Molecular engineering of extracellular vesicles for drug delivery: Strategies, challenges, and perspectives. J Control Release. 2025;386:114068. https:\/\/doi.org\/10.1016\/j.jconrel.2025.114068.","journal-title":"J Control Release"},{"key":"816_CR180","doi-asserted-by":"publisher","first-page":"11530","DOI":"10.3390\/ijms241411530","volume":"24","author":"A Salagean","year":"2023","unstructured":"Salagean A, Nechifor-Boila A, Bajwa N, Pastorello Y, Slevin M. Micro-Fragmented Adipose Tissue as a Natural Scaffold for Targeted Drug Delivery in Brain Cancer. Int J Mol Sci. 2023;24:11530. https:\/\/doi.org\/10.3390\/ijms241411530.","journal-title":"Int J Mol Sci"},{"key":"816_CR181","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1177\/15910199231169597","volume":"31","author":"J Lim","year":"2025","unstructured":"Lim J, Baig AA, Donnelly BM, Chaves LD, Pol SU, Koenigsknecht C, et al. The first endovascular rat glioma model for pre-clinical evaluation of intra-arterial therapeutics. Interv Neuroradiol. 2025;31:447\u201356. https:\/\/doi.org\/10.1177\/15910199231169597.","journal-title":"Interv Neuroradiol"},{"key":"816_CR182","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1038\/s41467-025-57263-1","volume":"16","author":"AJ Brenner","year":"2025","unstructured":"Brenner AJ, Patel T, Bao A, Phillips WT, Michalek JE, Youssef M, et al. Convection enhanced delivery of Rhenium (186Re) Obisbemeda (186RNL) in recurrent glioma: a multicenter, single arm, phase 1 clinical trial. Nat Commun. 2025;16:2079. https:\/\/doi.org\/10.1038\/s41467-025-57263-1.","journal-title":"Nat Commun"},{"key":"816_CR183","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.3390\/cancers5031020","volume":"5","author":"M van Woensel","year":"2013","unstructured":"van Woensel M, Wauthoz N, Rosi\u00e8re R, Amighi K, Mathieu V, Lefranc F, et al. Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM? Cancers (Basel). 2013;5:1020\u201348. https:\/\/doi.org\/10.3390\/cancers5031020.","journal-title":"Cancers (Basel)"},{"key":"816_CR184","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.brainresbull.2020.04.012","volume":"160","author":"LA Bors","year":"2020","unstructured":"Bors LA, Bajza \u00c1, M\u00e1ndoki M, Tasi BJ, Cserey G, Imre T, et al. Modulation of nose-to-brain delivery of a P-glycoprotein (MDR1) substrate model drug (quinidine) in rats. Brain Res Bull. 2020;160:65\u201373. https:\/\/doi.org\/10.1016\/j.brainresbull.2020.04.012.","journal-title":"Brain Res Bull"},{"key":"816_CR185","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.2174\/138161211797440159","volume":"17","author":"OO Ogunshola","year":"2011","unstructured":"Ogunshola OO. In vitro modeling of the blood-brain barrier: simplicity versus complexity. Curr Pharm Des. 2011;17:2755\u201361. https:\/\/doi.org\/10.2174\/138161211797440159.","journal-title":"Curr Pharm Des"},{"key":"816_CR186","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.neuint.2008.12.002","volume":"54","author":"S Nakagawa","year":"2009","unstructured":"Nakagawa S, Deli MA, Kawaguchi H, Shimizudani T, Shimono T, Kittel A, et al. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes. Neurochem Int. 2009;54:253\u201363. https:\/\/doi.org\/10.1016\/j.neuint.2008.12.002.","journal-title":"Neurochem Int"},{"key":"816_CR187","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s10571-013-9913-z","volume":"33","author":"K Toyoda","year":"2013","unstructured":"Toyoda K, Tanaka K, Nakagawa S, Thuy DHD, Ujifuku K, Kamada K, et al. Initial contact of glioblastoma cells with existing normal brain endothelial cells strengthen the barrier function via fibroblast growth factor 2 secretion: a new in vitro blood-brain barrier model. Cell Mol Neurobiol. 2013;33:489\u2013501. https:\/\/doi.org\/10.1007\/s10571-013-9913-z.","journal-title":"Cell Mol Neurobiol"},{"key":"816_CR188","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s10571-007-9195-4","volume":"27","author":"S Nakagawa","year":"2007","unstructured":"Nakagawa S, Deli MA, Nakao S, Honda M, Hayashi K, Nakaoke R, et al. Pericytes from brain microvessels strengthen the barrier integrity in primary cultures of rat brain endothelial cells. Cell Mol Neurobiol. 2007;27:687\u201394. https:\/\/doi.org\/10.1007\/s10571-007-9195-4.","journal-title":"Cell Mol Neurobiol"},{"key":"816_CR189","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.coche.2020.07.002","volume":"30","author":"ME Katt","year":"2020","unstructured":"Katt ME, Shusta EV. In vitro Models of the Blood-Brain Barrier: Building in physiological complexity. Curr Opin Chem Eng. 2020;30:42\u201352. https:\/\/doi.org\/10.1016\/j.coche.2020.07.002.","journal-title":"Curr Opin Chem Eng"},{"key":"816_CR190","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1021\/mp500046f","volume":"11","author":"I Wilhelm","year":"2014","unstructured":"Wilhelm I, Krizbai IA. In vitro models of the blood-brain barrier for the study of drug delivery to the brain. Mol Pharm. 2014;11:1949\u201363. https:\/\/doi.org\/10.1021\/mp500046f.","journal-title":"Mol Pharm"},{"key":"816_CR191","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/978-1-0716-2289-6_7","volume":"2492","author":"A Patabendige","year":"2022","unstructured":"Patabendige A. An Improved In Vitro Porcine Blood-Brain Barrier Model for Permeability Screening and Functional Studies. Methods Mol Biol. 2022;2492:131\u201342. https:\/\/doi.org\/10.1007\/978-1-0716-2289-6_7.","journal-title":"Methods Mol Biol"},{"key":"816_CR192","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1080\/01616412.2017.1398882","volume":"40","author":"S Yang","year":"2018","unstructured":"Yang S, Jin H, Zhao Z. An ECV304 monoculture model for permeability assessment of blood-brain barrier. Neurol Res. 2018;40:117\u201321. https:\/\/doi.org\/10.1080\/01616412.2017.1398882.","journal-title":"Neurol Res"},{"key":"816_CR193","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1089\/biores.2019.0026","volume":"8","author":"M Ohshima","year":"2019","unstructured":"Ohshima M, Kamei S, Fushimi H, Mima S, Yamada T, Yamamoto T. Prediction of Drug Permeability Using In Vitro Blood-Brain Barrier Models with Human Induced Pluripotent Stem Cell-Derived Brain Microvascular Endothelial Cells. Biores Open Access. 2019;8:200\u20139. https:\/\/doi.org\/10.1089\/biores.2019.0026.","journal-title":"Biores Open Access"},{"key":"816_CR194","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/2045-8118-10-33","volume":"10","author":"DE Eigenmann","year":"2013","unstructured":"Eigenmann DE, Xue G, Kim KS, Moses AV, Hamburger M, Oufir M. Comparative study of four immortalized human brain capillary endothelial cell lines, hCMEC\/D3, hBMEC, TY10, and BB19, and optimization of culture conditions, for an in vitro blood-brain barrier model for drug permeability studies. Fluids Barriers CNS. 2013;10:33. https:\/\/doi.org\/10.1186\/2045-8118-10-33.","journal-title":"Fluids Barriers CNS"},{"key":"816_CR195","doi-asserted-by":"publisher","first-page":"e0187017","DOI":"10.1371\/journal.pone.0187017","volume":"12","author":"S Yang","year":"2017","unstructured":"Yang S, Mei S, Jin H, Zhu B, Tian Y, Huo J, et al. Identification of two immortalized cell lines, ECV304 and bEnd3, for in vitro permeability studies of blood-brain barrier. PLoS ONE. 2017;12:e0187017. https:\/\/doi.org\/10.1371\/journal.pone.0187017.","journal-title":"PLoS ONE"},{"key":"816_CR196","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3390\/ijms24010533","volume":"24","author":"JD S\u00e1nchez-Mart\u00ednez","year":"2022","unstructured":"S\u00e1nchez-Mart\u00ednez JD, Garcia AR, Alvarez-Rivera G, Vald\u00e9s A, Brito MA, Cifuentes A. In Vitro Study of the Blood-Brain Barrier Transport of Natural Compounds Recovered from Agrifood By-Products and Microalgae. Int J Mol Sci. 2022;24:533. https:\/\/doi.org\/10.3390\/ijms24010533.","journal-title":"Int J Mol Sci"},{"key":"816_CR197","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12987-022-00336-w","volume":"19","author":"K Sato","year":"2022","unstructured":"Sato K, Nakagawa S, Morofuji Y, Matsunaga Y, Fujimoto T, Watanabe D, et al. Effects of fasudil on blood-brain barrier integrity. Fluids Barriers CNS. 2022;19:43. https:\/\/doi.org\/10.1186\/s12987-022-00336-w.","journal-title":"Fluids Barriers CNS"},{"key":"816_CR198","doi-asserted-by":"publisher","first-page":"5283","DOI":"10.3390\/ijms24065283","volume":"24","author":"JS Park","year":"2023","unstructured":"Park JS, Choe K, Khan A, Jo MH, Park HY, Kang MH, et al. Establishing Co-Culture Blood-Brain Barrier Models for Different Neurodegeneration Conditions to Understand Its Effect on BBB Integrity. Int J Mol Sci. 2023;24:5283. https:\/\/doi.org\/10.3390\/ijms24065283.","journal-title":"Int J Mol Sci"},{"key":"816_CR199","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.3390\/cells11142259","volume":"11","author":"P Lye","year":"2022","unstructured":"Lye P, Bloise E, Imperio GE, Chitayat D, Matthews SG. Functional Expression of Multidrug-Resistance (MDR) Transporters in Developing Human Fetal Brain Endothelial Cells. Cells. 2022;11:2259. https:\/\/doi.org\/10.3390\/cells11142259.","journal-title":"Cells"},{"key":"816_CR200","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1177\/2211068214561025","volume":"20","author":"B Srinivasan","year":"2015","unstructured":"Srinivasan B, Kolli AR, Esch MB, Abaci HE, Shuler ML, Hickman JJ. TEER measurement techniques for in vitro barrier model systems. J Lab Autom. 2015;20:107\u201326. https:\/\/doi.org\/10.1177\/2211068214561025.","journal-title":"J Lab Autom"},{"key":"816_CR201","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12987-020-00187-3","volume":"17","author":"MA Erickson","year":"2020","unstructured":"Erickson MA, Wilson ML, Banks WA. In vitro modeling of blood-brain barrier and interface functions in neuroimmune communication. Fluids Barriers CNS. 2020;17:26. https:\/\/doi.org\/10.1186\/s12987-020-00187-3.","journal-title":"Fluids Barriers CNS"},{"key":"816_CR202","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/2045-8118-10-16","volume":"10","author":"B Weksler","year":"2013","unstructured":"Weksler B, Romero IA, Couraud P-O. The hCMEC\/D3 cell line as a model of the human blood brain barrier. Fluids Barriers CNS. 2013;10:16. https:\/\/doi.org\/10.1186\/2045-8118-10-16.","journal-title":"Fluids Barriers CNS"},{"key":"816_CR203","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jconrel.2023.04.020","volume":"358","author":"D Qi","year":"2023","unstructured":"Qi D, Lin H, Hu B, Wei Y. A review on in vitro model of the blood-brain barrier (BBB) based on hCMEC\/D3 cells. J Control Release. 2023;358:78\u201397. https:\/\/doi.org\/10.1016\/j.jconrel.2023.04.020.","journal-title":"J Control Release"},{"key":"816_CR204","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.3390\/biomedicines11102700","volume":"11","author":"J Selvakumaran","year":"2023","unstructured":"Selvakumaran J, Ursu S, Bowerman M, Lu-Nguyen N, Wood MJ, Malerba A, et al. An Induced Pluripotent Stem Cell-Derived Human Blood-Brain Barrier (BBB) Model to Test the Crossing by Adeno-Associated Virus (AAV) Vectors and Antisense Oligonucleotides. Biomedicines. 2023;11:2700. https:\/\/doi.org\/10.3390\/biomedicines11102700.","journal-title":"Biomedicines"},{"key":"816_CR205","doi-asserted-by":"publisher","first-page":"651","DOI":"10.17305\/bjbms.2021.6943","volume":"22","author":"T Zidari\u010d","year":"2022","unstructured":"Zidari\u010d T, Gradi\u0161nik L, Velnar T. Astrocytes and human artificial blood-brain barrier models. Bosn J Basic Med Sci. 2022;22:651\u201372. https:\/\/doi.org\/10.17305\/bjbms.2021.6943.","journal-title":"Bosn J Basic Med Sci"},{"key":"816_CR206","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1161\/STROKEAHA.114.005427","volume":"45","author":"Y He","year":"2014","unstructured":"He Y, Yao Y, Tsirka SE, Cao Y. Cell-culture models of the blood-brain barrier. Stroke. 2014;45:2514\u201326. https:\/\/doi.org\/10.1161\/STROKEAHA.114.005427.","journal-title":"Stroke"},{"key":"816_CR207","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/7651_2024_537","volume":"2939","author":"M Rasouli","year":"2025","unstructured":"Rasouli M, Safari F. Principles of Indirect Co-culture Method Using Transwell. Methods Mol Biol. 2025;2939:257\u201363. https:\/\/doi.org\/10.1007\/7651_2024_537.","journal-title":"Methods Mol Biol"},{"key":"816_CR208","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1111\/jphp.12803","volume":"69","author":"C Kulczar","year":"2017","unstructured":"Kulczar C, Lubin KE, Lefebvre S, Miller DW, Knipp GT. Development of a direct contact astrocyte-human cerebral microvessel endothelial cells blood-brain barrier coculture model. J Pharm Pharmacol. 2017;69:1684\u201396. https:\/\/doi.org\/10.1111\/jphp.12803.","journal-title":"J Pharm Pharmacol"},{"key":"816_CR209","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.3390\/pharmaceutics15051431","volume":"15","author":"B S\u00e1nchez-Dengra","year":"2023","unstructured":"S\u00e1nchez-Dengra B, Garc\u00eda-Montoya E, Gonz\u00e1lez-\u00c1lvarez I, Bermejo M, Gonz\u00e1lez-\u00c1lvarez M. Establishment and Validation of a New Co-Culture for the Evaluation of the Permeability through the Blood-Brain Barrier in Patients with Glioblastoma. Pharmaceutics. 2023;15:1431. https:\/\/doi.org\/10.3390\/pharmaceutics15051431.","journal-title":"Pharmaceutics"},{"key":"816_CR210","doi-asserted-by":"publisher","first-page":"12699","DOI":"10.3390\/ijms241612699","volume":"24","author":"S Brandl","year":"2023","unstructured":"Brandl S, Reindl M. Blood-Brain Barrier Breakdown in Neuroinflammation: Current In Vitro Models. Int J Mol Sci. 2023;24:12699. https:\/\/doi.org\/10.3390\/ijms241612699.","journal-title":"Int J Mol Sci"},{"key":"816_CR211","doi-asserted-by":"publisher","first-page":"e0134765","DOI":"10.1371\/journal.pone.0134765","volume":"10","author":"LB Thomsen","year":"2015","unstructured":"Thomsen LB, Burkhart A, Moos T. A Triple Culture Model of the Blood-Brain Barrier Using Porcine Brain Endothelial cells, Astrocytes and Pericytes. PLoS ONE. 2015;10:e0134765. https:\/\/doi.org\/10.1371\/journal.pone.0134765.","journal-title":"PLoS ONE"},{"key":"816_CR212","doi-asserted-by":"publisher","unstructured":"Niego B, Medcalf RL. Improved method for the preparation of a human cell-based, contact model of the blood-brain barrier. J Vis Exp. 2013;e50934. https:\/\/doi.org\/10.3791\/50934.","DOI":"10.3791\/50934"},{"key":"816_CR213","doi-asserted-by":"publisher","first-page":"5949","DOI":"10.3390\/ijms26135949","volume":"26","author":"T Iwao","year":"2025","unstructured":"Iwao T, Takata F, Aridome H, Yasunaga M, Yokoya M, Mizoguchi J, et al. Brain Pericytes Enhance MFSD2A Expression and Plasma Membrane Localization in Brain Endothelial Cells Through the PDGF-BB\/PDGFR\u03b2 Signaling Pathway. Int J Mol Sci. 2025;26:5949. https:\/\/doi.org\/10.3390\/ijms26135949.","journal-title":"Int J Mol Sci"},{"key":"816_CR214","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1021\/acsmedchemlett.4c00398","volume":"15","author":"AL Iorio","year":"2024","unstructured":"Iorio AL, Lenci E, Marzano C, Bucaletti E, Tirinnanzi B, Casati G, et al. Oxime Linked Doxorubicin Glycoconjugates Improve the Specific Targeting of Glioblastoma in High-Grade Glioma Therapy. ACS Med Chem Lett. 2024;15:1953\u201360. https:\/\/doi.org\/10.1021\/acsmedchemlett.4c00398.","journal-title":"ACS Med Chem Lett"},{"key":"816_CR215","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s11060-024-04870-5","volume":"171","author":"X Mokoena","year":"2025","unstructured":"Mokoena X, Mabeta P, Cordier W, Flepisi BT. Glioblastoma cells alter brain endothelial cell homeostasis and tight junction protein expression in vitro. J Neurooncol. 2025;171:443\u201353. https:\/\/doi.org\/10.1007\/s11060-024-04870-5.","journal-title":"J Neurooncol"},{"key":"816_CR216","doi-asserted-by":"publisher","first-page":"e39343","DOI":"10.1016\/j.heliyon.2024.e39343","volume":"10","author":"P Kanjanasirirat","year":"2024","unstructured":"Kanjanasirirat P, Saengsawang W, Ketsawatsomkron P, Asavapanumas N, Borwornpinyo S, Soodvilai S, et al. GDNF and cAMP significantly enhance in vitro blood-brain barrier integrity in a humanized tricellular transwell model. Heliyon. 2024;10:e39343. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e39343.","journal-title":"Heliyon"},{"key":"816_CR217","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11910-024-01338-x","volume":"24","author":"KH Narsinh","year":"2024","unstructured":"Narsinh KH, Perez E, Haddad AF, Young JS, Savastano L, Villanueva-Meyer JE, et al. Strategies to Improve Drug Delivery Across the Blood-Brain Barrier for Glioblastoma. Curr Neurol Neurosci Rep. 2024;24:123\u201339. https:\/\/doi.org\/10.1007\/s11910-024-01338-x.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"816_CR218","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1080\/17425247.2024.2429702","volume":"21","author":"S Khot","year":"2024","unstructured":"Khot S, Krishnaveni A, Gharat S, Momin M, Bhavsar C, Omri A. Innovative drug delivery strategies for targeting glioblastoma: overcoming the challenges of the tumor microenvironment. Expert Opin Drug Deliv. 2024;21:1837\u201357. https:\/\/doi.org\/10.1080\/17425247.2024.2429702.","journal-title":"Expert Opin Drug Deliv"},{"key":"816_CR219","doi-asserted-by":"publisher","first-page":"101921","DOI":"10.1016\/j.arr.2023.101921","volume":"87","author":"W Bi","year":"2023","unstructured":"Bi W, Cai S, Lei T, Wang L. Implementation of blood-brain barrier on microfluidic chip: Recent advance and future prospects. Ageing Res Rev. 2023;87:101921. https:\/\/doi.org\/10.1016\/j.arr.2023.101921.","journal-title":"Ageing Res Rev"},{"key":"816_CR220","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.00830","author":"SC Massey","year":"2020","unstructured":"Massey SC, Urcuyo JC, Marin BM, Sarkaria JN, Swanson KR. Quantifying glioblastoma drug response dynamics incorporating treatment sensitivity and blood brain barrier penetrance from experimental data. Front Physiol. 2020;11:830. https:\/\/doi.org\/10.3389\/fphys.2020.00830."},{"key":"816_CR221","doi-asserted-by":"publisher","first-page":"120842","DOI":"10.1016\/j.biomaterials.2021.120842","volume":"275","author":"YW Naguib","year":"2021","unstructured":"Naguib YW, Saha S, Skeie JM, Acri T, Ebeid K, Abdel-Rahman S, et al. Solubilized ubiquinol for preserving corneal function. Biomaterials. 2021;275:120842. https:\/\/doi.org\/10.1016\/j.biomaterials.2021.120842.","journal-title":"Biomaterials"},{"key":"816_CR222","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s11912-025-01672-4","volume":"27","author":"G Thomas","year":"2025","unstructured":"Thomas G, Rahman R. Evolution of Preclinical Models for Glioblastoma Modelling and Drug Screening. Curr Oncol Rep. 2025;27:601\u201324. https:\/\/doi.org\/10.1007\/s11912-025-01672-4.","journal-title":"Curr Oncol Rep"},{"key":"816_CR223","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.3390\/cells10113183","volume":"10","author":"X Chen","year":"2021","unstructured":"Chen X, Liu C, Muok L, Zeng C, Li Y. Dynamic 3D On-Chip BBB Model Design, Development, and Applications in Neurological Diseases. Cells. 2021;10:3183. https:\/\/doi.org\/10.3390\/cells10113183.","journal-title":"Cells"},{"key":"816_CR224","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.tibtech.2019.04.006","volume":"37","author":"A Oddo","year":"2019","unstructured":"Oddo A, Peng B, Tong Z, Wei Y, Tong WY, Thissen H, et al. Advances in Microfluidic Blood-Brain Barrier (BBB) Models. Trends Biotechnol. 2019;37:1295\u2013314. https:\/\/doi.org\/10.1016\/j.tibtech.2019.04.006.","journal-title":"Trends Biotechnol"},{"key":"816_CR225","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41596-021-00635-w","volume":"17","author":"C Hajal","year":"2022","unstructured":"Hajal C, Offeddu GS, Shin Y, Zhang S, Morozova O, Hickman D, et al. Engineered human blood-brain barrier microfluidic model for vascular permeability analyses. Nat Protoc. 2022;17:95\u2013128. https:\/\/doi.org\/10.1038\/s41596-021-00635-w.","journal-title":"Nat Protoc"},{"key":"816_CR226","doi-asserted-by":"publisher","first-page":"e2201401","DOI":"10.1002\/smll.202201401","volume":"18","author":"S Kawakita","year":"2022","unstructured":"Kawakita S, Mandal K, Mou L, Mecwan MM, Zhu Y, Li S, et al. Organ-On-A-Chip Models of the Blood-Brain Barrier: Recent Advances and Future Prospects. Small. 2022;18:e2201401. https:\/\/doi.org\/10.1002\/smll.202201401.","journal-title":"Small"},{"key":"816_CR227","doi-asserted-by":"publisher","first-page":"572","DOI":"10.3390\/bioengineering10050572","volume":"10","author":"I M\u00e1rmol","year":"2023","unstructured":"M\u00e1rmol I, Abizanda-Campo S, Ayuso JM, Ochoa I, Oliv\u00e1n S. Towards Novel Biomimetic In Vitro Models of the Blood-Brain Barrier for Drug Permeability Evaluation. Bioeng (Basel). 2023;10:572. https:\/\/doi.org\/10.3390\/bioengineering10050572.","journal-title":"Bioeng (Basel)"},{"key":"816_CR228","doi-asserted-by":"publisher","first-page":"e2405511","DOI":"10.1002\/smll.202405511","volume":"21","author":"S Maity","year":"2025","unstructured":"Maity S, Bhuyan T, Jewell C, Kawakita S, Sharma S, Nguyen HT, et al. Recent Developments in Glioblastoma-On-A-Chip for Advanced Drug Screening Applications. Small. 2025;21:e2405511. https:\/\/doi.org\/10.1002\/smll.202405511.","journal-title":"Small"},{"key":"816_CR229","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1002\/bit.26221","volume":"114","author":"AP Falanga","year":"2017","unstructured":"Falanga AP, Pitingolo G, Celentano M, Cosentino A, Melone P, Vecchione R, et al. Shuttle-mediated nanoparticle transport across an in vitro brain endothelium under flow conditions. Biotechnol Bioeng. 2017;114:1087\u201395. https:\/\/doi.org\/10.1002\/bit.26221.","journal-title":"Biotechnol Bioeng"},{"key":"816_CR230","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3390\/cells14060456","volume":"14","author":"Y Li","year":"2025","unstructured":"Li Y, Fu BM. A Cost-Effective and Easy to Assemble 3D Human Microchannel Blood-Brain Barrier Model and Its Application in Tumor Cell Adhesion Under Flow. Cells. 2025;14:456. https:\/\/doi.org\/10.3390\/cells14060456.","journal-title":"Cells"},{"key":"816_CR231","doi-asserted-by":"publisher","first-page":"054124","DOI":"10.1063\/1.4934713","volume":"9","author":"JA Brown","year":"2015","unstructured":"Brown JA, Pensabene V, Markov DA, Allwardt V, Neely MD, Shi M, et al. Recreating blood-brain barrier physiology and structure on chip: A novel neurovascular microfluidic bioreactor. Biomicrofluidics. 2015;9:054124. https:\/\/doi.org\/10.1063\/1.4934713.","journal-title":"Biomicrofluidics"},{"key":"816_CR232","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.1021\/acsbiomaterials.4c02221","volume":"11","author":"GG da Silva","year":"2025","unstructured":"da Silva GG, Sacomani DP, de Carvalho BG, Porcionatto MA, Gobbi A, Lima RS, et al. Microfluidic Systems to Mimic the Blood-Brain Barrier: from Market to Engineering Challenges and Perspectives. ACS Biomater Sci Eng. 2025;11:3789\u2013815. https:\/\/doi.org\/10.1021\/acsbiomaterials.4c02221.","journal-title":"ACS Biomater Sci Eng"},{"key":"816_CR233","doi-asserted-by":"publisher","first-page":"e4070","DOI":"10.21769\/BioProtoc.4070","volume":"11","author":"A Junaid","year":"2021","unstructured":"Junaid A, Hankemeier T. OrganoPlate Micro-fluidic Microvessel Culture and Analysis. Bio Protoc. 2021;11:e4070. https:\/\/doi.org\/10.21769\/BioProtoc.4070.","journal-title":"Bio Protoc"},{"key":"816_CR234","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/978-1-0716-2289-6_13","volume":"2492","author":"D Sooriyaarachchi","year":"2022","unstructured":"Sooriyaarachchi D, Maharubin S, Tan GZ. Fabrication of Microtube-Embedded Chip to Mimic Blood-Brain Barrier Capillary Vessels. Methods Mol Biol. 2022;2492:241\u20139. https:\/\/doi.org\/10.1007\/978-1-0716-2289-6_13.","journal-title":"Methods Mol Biol"},{"key":"816_CR235","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3390\/mi10060375","volume":"10","author":"L Jiang","year":"2019","unstructured":"Jiang L, Li S, Zheng J, Li Y, Huang H. Recent Progress in Microfluidic Models of the Blood-Brain Barrier. Micromachines (Basel). 2019;10:375. https:\/\/doi.org\/10.3390\/mi10060375.","journal-title":"Micromachines (Basel)"},{"key":"816_CR236","doi-asserted-by":"publisher","first-page":"110822","DOI":"10.1016\/j.biopha.2020.110822","volume":"132","author":"X Wang","year":"2020","unstructured":"Wang X, Hou Y, Ai X, Sun J, Xu B, Meng X, et al. Potential applications of microfluidics based blood brain barrier (BBB)-on-chips for in vitro drug development. Biomed Pharmacother. 2020;132:110822. https:\/\/doi.org\/10.1016\/j.biopha.2020.110822.","journal-title":"Biomed Pharmacother"},{"key":"816_CR237","doi-asserted-by":"publisher","first-page":"4173","DOI":"10.1007\/s10571-023-01404-x","volume":"43","author":"F Burgio","year":"2023","unstructured":"Burgio F, Gaiser C, Brady K, Gatta V, Class R, Schrage R, et al. A Perfused In Vitro Human iPSC-Derived Blood-Brain Barrier Faithfully Mimics Transferrin Receptor-Mediated Transcytosis of Therapeutic Antibodies. Cell Mol Neurobiol. 2023;43:4173\u201387. https:\/\/doi.org\/10.1007\/s10571-023-01404-x.","journal-title":"Cell Mol Neurobiol"},{"key":"816_CR238","doi-asserted-by":"publisher","DOI":"10.3791\/58900","author":"W Zhao","year":"2019","unstructured":"Zhao W, Han L, Bae Y, Manickam DS. Lucifer Yellow - A Robust Paracellular Permeability Marker in a Cell Model of the Human Blood-brain Barrier. J Vis Exp. 2019. https:\/\/doi.org\/10.3791\/58900.","journal-title":"J Vis Exp"},{"key":"816_CR239","doi-asserted-by":"publisher","first-page":"031005","DOI":"10.1115\/1.4025892","volume":"136","author":"L Shi","year":"2014","unstructured":"Shi L, Zeng M, Sun Y, Fu BM. Quantification of blood-brain barrier solute permeability and brain transport by multiphoton microscopy. J Biomech Eng. 2014;136:031005. https:\/\/doi.org\/10.1115\/1.4025892.","journal-title":"J Biomech Eng"},{"key":"816_CR240","doi-asserted-by":"publisher","first-page":"100324","DOI":"10.1016\/j.mtbio.2022.100324","volume":"15","author":"M Piantino","year":"2022","unstructured":"Piantino M, Kang D-H, Furihata T, Nakatani N, Kitamura K, Shigemoto-Mogami Y, et al. Development of a three-dimensional blood-brain barrier network with opening capillary structures for drug transport screening assays. Mater Today Bio. 2022;15:100324. https:\/\/doi.org\/10.1016\/j.mtbio.2022.100324.","journal-title":"Mater Today Bio"},{"key":"816_CR241","doi-asserted-by":"publisher","first-page":"e2411361","DOI":"10.1002\/smll.202411361","volume":"21","author":"T DePalma","year":"2025","unstructured":"DePalma T, Rodriguez M, Kollin L, Hughes K, Jones K, Stagner E, et al. A Microfluidic Blood Brain Barrier Model to Study the Influence of Glioblastoma Tumor Cells on BBB Function. Small. 2025;21:e2411361. https:\/\/doi.org\/10.1002\/smll.202411361.","journal-title":"Small"},{"key":"816_CR242","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.jconrel.2024.04.011","volume":"369","author":"J Zhou","year":"2024","unstructured":"Zhou J, Meng N, Lu L, Lu J, Wu S, Ding Y, et al. A novel peptide-drug conjugate for glioma-targeted drug delivery. J Control Release. 2024;369:722\u201333. https:\/\/doi.org\/10.1016\/j.jconrel.2024.04.011.","journal-title":"J Control Release"},{"key":"816_CR243","doi-asserted-by":"publisher","first-page":"e2118697119","DOI":"10.1073\/pnas.2118697119","volume":"119","author":"JP Straehla","year":"2022","unstructured":"Straehla JP, Hajal C, Safford HC, Offeddu GS, Boehnke N, Dacoba TG, et al. A predictive microfluidic model of human glioblastoma to assess trafficking of blood-brain barrier-penetrant nanoparticles. Proc Natl Acad Sci U S A. 2022;119:e2118697119. https:\/\/doi.org\/10.1073\/pnas.2118697119.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"816_CR244","doi-asserted-by":"publisher","first-page":"e2401876","DOI":"10.1002\/adhm.202401876","volume":"13","author":"S Pun","year":"2024","unstructured":"Pun S, Prakash A, Demaree D, Krummel DP, Scium\u00e8 G, Sengupta S, et al. Rapid Biofabrication of an Advanced Microphysiological System Mimicking Phenotypical Heterogeneity and Drug Resistance in Glioblastoma. Adv Healthc Mater. 2024;13:e2401876. https:\/\/doi.org\/10.1002\/adhm.202401876.","journal-title":"Adv Healthc Mater"},{"key":"816_CR245","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.3390\/cancers14041013","volume":"14","author":"C Vitale","year":"2022","unstructured":"Vitale C, Marzagalli M, Scaglione S, Dondero A, Bottino C, Castriconi R. Tumor Microenvironment and Hydrogel-Based 3D Cancer Models for In Vitro Testing Immunotherapies. Cancers (Basel). 2022;14:1013. https:\/\/doi.org\/10.3390\/cancers14041013.","journal-title":"Cancers (Basel)"},{"key":"816_CR246","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.3390\/s22041517","volume":"22","author":"A Fedi","year":"2022","unstructured":"Fedi A, Vitale C, Giannoni P, Caluori G, Marrella A. Biosensors to Monitor Cell Activity in 3D Hydrogel-Based Tissue Models. Sens (Basel). 2022;22:1517. https:\/\/doi.org\/10.3390\/s22041517.","journal-title":"Sens (Basel)"},{"key":"816_CR247","doi-asserted-by":"publisher","first-page":"993","DOI":"10.3390\/pharmaceutics14050993","volume":"14","author":"A Sood","year":"2022","unstructured":"Sood A, Kumar A, Dev A, Gupta VK, Han SS. Advances in Hydrogel-Based Microfluidic Blood-Brain-Barrier Models in Oncology Research. Pharmaceutics. 2022;14:993. https:\/\/doi.org\/10.3390\/pharmaceutics14050993.","journal-title":"Pharmaceutics"},{"key":"816_CR248","doi-asserted-by":"publisher","first-page":"101087","DOI":"10.1016\/j.tranon.2021.101087","volume":"14","author":"R Augustine","year":"2021","unstructured":"Augustine R, Aqel AH, Kalva SN, Joshy KS, Nayeem A, Hasan A. Bioengineered microfluidic blood-brain barrier models in oncology research. Transl Oncol. 2021;14:101087. https:\/\/doi.org\/10.1016\/j.tranon.2021.101087.","journal-title":"Transl Oncol"},{"key":"816_CR249","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-13993-7","volume":"11","author":"J-M Oh","year":"2020","unstructured":"Oh J-M, Venters CC, Di C, Pinto AM, Wan L, Younis I, et al. U1 snRNP regulates cancer cell migration and invasion in vitro. Nat Commun. 2020;11:1. https:\/\/doi.org\/10.1038\/s41467-019-13993-7.","journal-title":"Nat Commun"},{"key":"816_CR250","doi-asserted-by":"publisher","first-page":"NS20210027","DOI":"10.1042\/NS20210027","volume":"5","author":"G Potjewyd","year":"2021","unstructured":"Potjewyd G, Kellett KAB, Hooper NM. 3D hydrogel models of the neurovascular unit to investigate blood-brain barrier dysfunction. Neuronal Signal. 2021;5:NS20210027. https:\/\/doi.org\/10.1042\/NS20210027.","journal-title":"Neuronal Signal"},{"key":"816_CR251","doi-asserted-by":"publisher","first-page":"43682","DOI":"10.1039\/d0ra08566a","volume":"10","author":"F Akther","year":"2020","unstructured":"Akther F, Little P, Li Z, Nguyen N-T, Ta HT. Hydrogels as artificial matrices for cell seeding in microfluidic devices. RSC Adv. 2020;10:43682\u2013703. https:\/\/doi.org\/10.1039\/d0ra08566a.","journal-title":"RSC Adv"},{"key":"816_CR252","doi-asserted-by":"publisher","first-page":"745","DOI":"10.3389\/fbioe.2020.00745","volume":"8","author":"G Tang","year":"2020","unstructured":"Tang G, Zhou B, Li F, Wang W, Liu Y, Wang X, et al. Advances of Naturally Derived and Synthetic Hydrogels for Intervertebral Disk Regeneration. Front Bioeng Biotechnol. 2020;8:745. https:\/\/doi.org\/10.3389\/fbioe.2020.00745.","journal-title":"Front Bioeng Biotechnol"},{"key":"816_CR253","doi-asserted-by":"publisher","first-page":"65754","DOI":"10.1021\/acsami.4c11855","volume":"16","author":"S Zhang","year":"2024","unstructured":"Zhang S, Zhong R, Younis MR, He H, Xu H, Li G, et al. Hydrogel Applications in the Diagnosis and Treatment of Glioblastoma. ACS Appl Mater Interfaces. 2024;16:65754\u201378. https:\/\/doi.org\/10.1021\/acsami.4c11855.","journal-title":"ACS Appl Mater Interfaces"},{"key":"816_CR254","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.3390\/pharmaceutics13071053","volume":"13","author":"JL King","year":"2021","unstructured":"King JL, Benhabbour SR. Glioblastoma Multiforme-A Look at the Past and a Glance at the Future. Pharmaceutics. 2021;13:1053. https:\/\/doi.org\/10.3390\/pharmaceutics13071053.","journal-title":"Pharmaceutics"},{"key":"816_CR255","doi-asserted-by":"publisher","first-page":"25062","DOI":"10.1038\/srep25062","volume":"6","author":"Y Fan","year":"2016","unstructured":"Fan Y, Nguyen DT, Akay Y, Xu F, Akay M. Engineering a Brain Cancer Chip for High-throughput Drug Screening. Sci Rep. 2016;6:25062. https:\/\/doi.org\/10.1038\/srep25062.","journal-title":"Sci Rep"},{"key":"816_CR256","doi-asserted-by":"publisher","first-page":"e0283954","DOI":"10.1371\/journal.pone.0283954","volume":"18","author":"NR Singh","year":"2023","unstructured":"Singh NR, Gromnicova R, Brachner A, Kraev I, Romero IA, Neuhaus W, et al. A hydrogel model of the human blood-brain barrier using differentiated stem cells. PLoS ONE. 2023;18:e0283954. https:\/\/doi.org\/10.1371\/journal.pone.0283954.","journal-title":"PLoS ONE"},{"key":"816_CR257","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1080\/10837450.2021.1872624","volume":"26","author":"R Augustine","year":"2021","unstructured":"Augustine R, Zahid AA, Mraiche F, Alam K, Al Moustafa A-E, Hasan A. Gelatin-methacryloyl hydrogel based in vitro blood-brain barrier model for studying breast cancer-associated brain metastasis. Pharm Dev Technol. 2021;26:490\u2013500. https:\/\/doi.org\/10.1080\/10837450.2021.1872624.","journal-title":"Pharm Dev Technol"},{"key":"816_CR258","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1038\/srep01500","volume":"3","author":"E Urich","year":"2013","unstructured":"Urich E, Patsch C, Aigner S, Graf M, Iacone R, Freskg\u00e5rd P-O. Multicellular self-assembled spheroidal model of the blood brain barrier. Sci Rep. 2013;3:1500. https:\/\/doi.org\/10.1038\/srep01500.","journal-title":"Sci Rep"},{"key":"816_CR259","doi-asserted-by":"publisher","first-page":"10148","DOI":"10.7150\/thno.63195","volume":"11","author":"L Yan","year":"2021","unstructured":"Yan L, Moriarty RA, Stroka KM. Recent progress and new challenges in modeling of human pluripotent stem cell-derived blood-brain barrier. Theranostics. 2021;11:10148\u201370. https:\/\/doi.org\/10.7150\/thno.63195.","journal-title":"Theranostics"},{"key":"816_CR260","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.3390\/molecules29112469","volume":"29","author":"K Kostka","year":"2024","unstructured":"Kostka K, Sokolova V, El-Taibany A, Kruse B, Porada D, Wolff N, et al. The Application of Ultrasmall Gold Nanoparticles (2 nm) Functionalized with Doxorubicin in Three-Dimensional Normal and Glioblastoma Organoid Models of the Blood-Brain Barrier. Molecules. 2024;29:2469. https:\/\/doi.org\/10.3390\/molecules29112469.","journal-title":"Molecules"},{"key":"816_CR261","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1038\/s41596-018-0066-x","volume":"13","author":"S Bergmann","year":"2018","unstructured":"Bergmann S, Lawler SE, Qu Y, Fadzen CM, Wolfe JM, Regan MS, et al. Blood-brain-barrier organoids for investigating the permeability of CNS therapeutics. Nat Protoc. 2018;13:2827\u201343. https:\/\/doi.org\/10.1038\/s41596-018-0066-x.","journal-title":"Nat Protoc"},{"key":"816_CR262","doi-asserted-by":"publisher","first-page":"15623","DOI":"10.1038\/ncomms15623","volume":"8","author":"C-F Cho","year":"2017","unstructured":"Cho C-F, Wolfe JM, Fadzen CM, Calligaris D, Hornburg K, Chiocca EA, et al. Blood-brain-barrier spheroids as an in vitro screening platform for brain-penetrating agents. Nat Commun. 2017;8:15623. https:\/\/doi.org\/10.1038\/ncomms15623.","journal-title":"Nat Commun"},{"key":"816_CR263","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12987-020-00191-7","volume":"17","author":"MJ Workman","year":"2020","unstructured":"Workman MJ, Svendsen CN. Recent advances in human iPSC-derived models of the blood-brain barrier. Fluids Barriers CNS. 2020;17:30. https:\/\/doi.org\/10.1186\/s12987-020-00191-7.","journal-title":"Fluids Barriers CNS"},{"key":"816_CR264","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1002\/stem.2908","volume":"36","author":"L Delsing","year":"2018","unstructured":"Delsing L, D\u00f6nnes P, S\u00e1nchez J, Clausen M, Voulgaris D, Falk A, et al. Barrier Properties and Transcriptome Expression in Human iPSC-Derived Models of the Blood-Brain Barrier. Stem Cells. 2018;36:1816\u201327. https:\/\/doi.org\/10.1002\/stem.2908.","journal-title":"Stem Cells"},{"key":"816_CR265","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12987-017-0059-0","volume":"14","author":"EK Hollmann","year":"2017","unstructured":"Hollmann EK, Bailey AK, Potharazu AV, Neely MD, Bowman AB, Lippmann ES. Accelerated differentiation of human induced pluripotent stem cells to blood-brain barrier endothelial cells. Fluids Barriers CNS. 2017;14:9. https:\/\/doi.org\/10.1186\/s12987-017-0059-0.","journal-title":"Fluids Barriers CNS"},{"key":"816_CR266","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.bbrc.2017.03.092","volume":"486","author":"Y Kokubu","year":"2017","unstructured":"Kokubu Y, Yamaguchi T, Kawabata K. In vitro model of cerebral ischemia by using brain microvascular endothelial cells derived from human induced pluripotent stem cells. Biochem Biophys Res Commun. 2017;486:577\u201383. https:\/\/doi.org\/10.1016\/j.bbrc.2017.03.092.","journal-title":"Biochem Biophys Res Commun"},{"key":"816_CR267","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13619-021-00103-6","volume":"11","author":"X Lu","year":"2022","unstructured":"Lu X, Yang J, Xiang Y. Modeling human neurodevelopmental diseases with brain organoids. Cell Regen. 2022;11:1. https:\/\/doi.org\/10.1186\/s13619-021-00103-6.","journal-title":"Cell Regen"},{"key":"816_CR268","doi-asserted-by":"publisher","first-page":"110544","DOI":"10.1016\/j.jneumeth.2025.110544","volume":"423","author":"I Bano","year":"2025","unstructured":"Bano I, Jeevanandam J, Tsenov G. Effects of focused ultrasound stimulation on various in vitro neurological cell models. J Neurosci Methods. 2025;423:110544. https:\/\/doi.org\/10.1016\/j.jneumeth.2025.110544.","journal-title":"J Neurosci Methods"},{"key":"816_CR269","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3390\/cells12030503","volume":"12","author":"M M\u00e9sz\u00e1ros","year":"2023","unstructured":"M\u00e9sz\u00e1ros M, Phan THM, Vigh JP, Porkol\u00e1b G, Kocsis A, P\u00e1li EK, et al. Targeting Human Endothelial Cells with Glutathione and Alanine Increases the Crossing of a Polypeptide Nanocarrier through a Blood-Brain Barrier Model and Entry to Human Brain Organoids. Cells. 2023;12:503. https:\/\/doi.org\/10.3390\/cells12030503.","journal-title":"Cells"},{"key":"816_CR270","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/978-3-030-34025-4_20","volume":"1219","author":"N Mendes","year":"2020","unstructured":"Mendes N, Dias Carvalho P, Martins F, Mendon\u00e7a S, Malheiro AR, Ribeiro A, et al. Animal Models to Study Cancer and Its Microenvironment. Adv Exp Med Biol. 2020;1219:389\u2013401. https:\/\/doi.org\/10.1007\/978-3-030-34025-4_20.","journal-title":"Adv Exp Med Biol"},{"key":"816_CR271","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1517\/17425255.2012.677433","volume":"8","author":"WJ Geldenhuys","year":"2012","unstructured":"Geldenhuys WJ, Allen DD, Bloomquist JR. Novel models for assessing blood-brain barrier drug permeation. Expert Opin Drug Metab Toxicol. 2012;8:647\u201353. https:\/\/doi.org\/10.1517\/17425255.2012.677433.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"816_CR272","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.bbcan.2013.04.003","volume":"1836","author":"L Chen","year":"2013","unstructured":"Chen L, Zhang Y, Yang J, Hagan JP, Li M. Vertebrate animal models of glioma: understanding the mechanisms and developing new therapies. Biochim Biophys Acta. 2013;1836:158\u201365. https:\/\/doi.org\/10.1016\/j.bbcan.2013.04.003.","journal-title":"Biochim Biophys Acta"},{"key":"816_CR273","doi-asserted-by":"publisher","first-page":"4904","DOI":"10.1038\/s41467-018-07334-3","volume":"9","author":"EC Randall","year":"2018","unstructured":"Randall EC, Emdal KB, Laramy JK, Kim M, Roos A, Calligaris D, et al. Integrated mapping of pharmacokinetics and pharmacodynamics in a patient-derived xenograft model of glioblastoma. Nat Commun. 2018;9:4904. https:\/\/doi.org\/10.1038\/s41467-018-07334-3.","journal-title":"Nat Commun"},{"key":"816_CR274","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41392-023-01419-2","volume":"8","author":"Y Liu","year":"2023","unstructured":"Liu Y, Wu W, Cai C, Zhang H, Shen H, Han Y. Patient-derived xenograft models in cancer therapy: technologies and applications. Signal Transduct Target Ther. 2023;8:160. https:\/\/doi.org\/10.1038\/s41392-023-01419-2.","journal-title":"Signal Transduct Target Ther"},{"key":"816_CR275","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s13104-024-06900-x","volume":"17","author":"LR Neitzel","year":"2024","unstructured":"Neitzel LR, Fuller DT, Williams CH, Hong CC. Inhibition of GPR68 kills glioblastoma in zebrafish xenograft models. BMC Res Notes. 2024;17:235. https:\/\/doi.org\/10.1186\/s13104-024-06900-x.","journal-title":"BMC Res Notes"},{"key":"816_CR276","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41698-025-01001-9","volume":"9","author":"L Han","year":"2025","unstructured":"Han L, Wang H, Xie H, Yu X, Zhou H, Guo Z. Deciphering the YY1\/ lncRNA BLACAT1\/miR-605-3p axis in glioblastoma: implications for therapy. NPJ Precis Oncol. 2025;9:213. https:\/\/doi.org\/10.1038\/s41698-025-01001-9.","journal-title":"NPJ Precis Oncol"},{"key":"816_CR277","doi-asserted-by":"publisher","first-page":"101557","DOI":"10.1016\/j.tice.2021.101557","volume":"72","author":"T Dugand\u017eija","year":"2021","unstructured":"Dugand\u017eija T, Drlja\u010da J, Bulaji\u0107 D, Isakovi\u0107 A, Stilinovi\u0107 N, Sekuli\u0107 S, et al. Hallmarks of tumor-associated microglia response to experimental U87 human glioblastoma xenograft. Tissue Cell. 2021;72:101557. https:\/\/doi.org\/10.1016\/j.tice.2021.101557.","journal-title":"Tissue Cell"},{"key":"816_CR278","doi-asserted-by":"publisher","first-page":"712","DOI":"10.3390\/cells10030712","volume":"10","author":"WH Hicks","year":"2021","unstructured":"Hicks WH, Bird CE, Traylor JI, Shi DD, El Ahmadieh TY, Richardson TE, et al. Contemporary Mouse Models in Glioma Research. Cells. 2021;10:712. https:\/\/doi.org\/10.3390\/cells10030712.","journal-title":"Cells"},{"key":"816_CR279","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12987-025-00695-0","volume":"22","author":"J Shin","year":"2025","unstructured":"Shin J, Shim J-K, Kong C, Seo Y, Han S, Kang S-G, et al. Focused ultrasound-mediated temozolomide delivery into intact blood-brain barrier tissue improves survival in patient-derived xenograft model of glioblastoma. Fluids Barriers CNS. 2025;22:87. https:\/\/doi.org\/10.1186\/s12987-025-00695-0.","journal-title":"Fluids Barriers CNS"},{"key":"816_CR280","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1093\/neuonc\/noae059","volume":"26","author":"S Budhiraja","year":"2024","unstructured":"Budhiraja S, McManus G, Baisiwala S, Perrault EN, Cho S, Saathoff M, et al. ARF4-mediated retrograde trafficking as a driver of chemoresistance in glioblastoma. Neuro Oncol. 2024;26:1421\u201337. https:\/\/doi.org\/10.1093\/neuonc\/noae059.","journal-title":"Neuro Oncol"},{"key":"816_CR281","doi-asserted-by":"publisher","first-page":"dmm049109","DOI":"10.1242\/dmm.049109","volume":"15","author":"X Ai","year":"2022","unstructured":"Ai X, Ye Z, Xiao C, Zhong J, Lancman JJ, Chen X, et al. Clinically relevant orthotopic xenograft models of patient-derived glioblastoma in zebrafish. Dis Model Mech. 2022;15:dmm049109. https:\/\/doi.org\/10.1242\/dmm.049109.","journal-title":"Dis Model Mech"},{"key":"816_CR282","doi-asserted-by":"publisher","first-page":"108631","DOI":"10.1016\/j.pharmthera.2024.108631","volume":"257","author":"SM Stribbling","year":"2024","unstructured":"Stribbling SM, Beach C, Ryan AJ. Orthotopic and metastatic tumour models in preclinical cancer research. Pharmacol Ther. 2024;257:108631. https:\/\/doi.org\/10.1016\/j.pharmthera.2024.108631.","journal-title":"Pharmacol Ther"},{"key":"816_CR283","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1038\/s41467-023-37306-1","volume":"14","author":"W Lin","year":"2023","unstructured":"Lin W, Niu R, Park S-M, Zou Y, Kim SS, Xia X, et al. IGFBP5 is an ROR1 ligand promoting glioblastoma invasion via ROR1\/HER2-CREB signaling axis. Nat Commun. 2023;14:1578. https:\/\/doi.org\/10.1038\/s41467-023-37306-1.","journal-title":"Nat Commun"},{"key":"816_CR284","doi-asserted-by":"publisher","first-page":"100982","DOI":"10.1016\/j.neo.2024.100982","volume":"50","author":"S Uchida","year":"2024","unstructured":"Uchida S, Serada S, Suzuki Y, Funajima E, Kitakami K, Dobashi K, et al. Glypican-1-targeted antibody-drug conjugate inhibits the growth of glypican-1-positive glioblastoma. Neoplasia. 2024;50:100982. https:\/\/doi.org\/10.1016\/j.neo.2024.100982.","journal-title":"Neoplasia"},{"key":"816_CR285","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1093\/neuonc\/nos135","volume":"14","author":"PC Huszthy","year":"2012","unstructured":"Huszthy PC, Daphu I, Niclou SP, Stieber D, Nigro JM, Sakariassen P\u00d8, et al. In vivo models of primary brain tumors: pitfalls and perspectives. Neuro Oncol. 2012;14:979\u201393. https:\/\/doi.org\/10.1093\/neuonc\/nos135.","journal-title":"Neuro Oncol"},{"key":"816_CR286","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1158\/1078-0432.CCR-14-2588","volume":"21","author":"JL Pokorny","year":"2015","unstructured":"Pokorny JL, Calligaris D, Gupta SK, Iyekegbe DO, Mueller D, Bakken KK, et al. The Efficacy of the Wee1 Inhibitor MK-1775 Combined with Temozolomide Is Limited by Heterogeneous Distribution across the Blood-Brain Barrier in Glioblastoma. Clin Cancer Res. 2015;21:1916\u201324. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-2588.","journal-title":"Clin Cancer Res"},{"key":"816_CR287","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1093\/neuonc\/noab244","volume":"24","author":"AM Barrette","year":"2022","unstructured":"Barrette AM, Ronk H, Joshi T, Mussa Z, Mehrotra M, Bouras A, et al. Anti-invasive efficacy and survival benefit of the YAP-TEAD inhibitor verteporfin in preclinical glioblastoma models. Neuro Oncol. 2022;24:694\u2013707. https:\/\/doi.org\/10.1093\/neuonc\/noab244.","journal-title":"Neuro Oncol"},{"key":"816_CR288","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/s00262-024-03808-0","volume":"73","author":"T Tachi","year":"2024","unstructured":"Tachi T, Kijima N, Kuroda H, Ikeda S, Murakami K, Nakagawa T, et al. Antitumor effects of intracranial injection of B7-H3-targeted Car-T and Car-Nk cells in a patient-derived glioblastoma xenograft model. Cancer Immunol Immunother. 2024;73:256. https:\/\/doi.org\/10.1007\/s00262-024-03808-0.","journal-title":"Cancer Immunol Immunother"},{"key":"816_CR289","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1093\/neuonc\/noae131","volume":"26","author":"J Figg","year":"2024","unstructured":"Figg J, Chen D, Falceto Font L, Flores C, Jin D. In vivo mouse models for adult brain tumors: Exploring tumorigenesis and advancing immunotherapy development. Neuro Oncol. 2024;26:1964\u201380. https:\/\/doi.org\/10.1093\/neuonc\/noae131.","journal-title":"Neuro Oncol"},{"key":"816_CR290","doi-asserted-by":"publisher","first-page":"137","DOI":"10.15252\/emmm.201606857","volume":"9","author":"K Kersten","year":"2017","unstructured":"Kersten K, de Visser KE, van Miltenburg MH, Jonkers J. Genetically engineered mouse models in oncology research and cancer medicine. EMBO Mol Med. 2017;9:137\u201353. https:\/\/doi.org\/10.15252\/emmm.201606857.","journal-title":"EMBO Mol Med"},{"key":"816_CR291","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/978-1-4939-7845-8_11","volume":"1786","author":"CWD Armstrong","year":"2018","unstructured":"Armstrong CWD, Lyubomska O, LaBonte MJ, Waugh DJJ. Protocols for Studies on Genetically Engineered Mouse Models in Prostate Cancer. Methods Mol Biol. 2018;1786:195\u2013206. https:\/\/doi.org\/10.1007\/978-1-4939-7845-8_11.","journal-title":"Methods Mol Biol"},{"key":"816_CR292","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41568-023-00627-w","volume":"24","author":"N Mathey-Andrews","year":"2024","unstructured":"Mathey-Andrews N. Prime editing GEMMs to model cancer mutations. Nat Rev Cancer. 2024;24:2. https:\/\/doi.org\/10.1038\/s41568-023-00627-w.","journal-title":"Nat Rev Cancer"},{"key":"816_CR293","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1158\/1078-0432.CCR-22-3379","volume":"29","author":"SA Patel","year":"2023","unstructured":"Patel SA, Nilsson MB, Yang Y, Le X, Tran HT, Elamin YY, et al. IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC. Clin Cancer Res. 2023;29:1292\u2013304. https:\/\/doi.org\/10.1158\/1078-0432.CCR-22-3379.","journal-title":"Clin Cancer Res"},{"key":"816_CR294","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1101\/gad.274134.115","volume":"30","author":"U Santanam","year":"2016","unstructured":"Santanam U, Banach-Petrosky W, Abate-Shen C, Shen MM, White E, DiPaola RS. Atg7 cooperates with Pten loss to drive prostate cancer tumor growth. Genes Dev. 2016;30:399\u2013407. https:\/\/doi.org\/10.1101\/gad.274134.115.","journal-title":"Genes Dev"},{"key":"816_CR295","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.3390\/cancers17172759","volume":"17","author":"Y Zhai","year":"2025","unstructured":"Zhai Y, Fearon ER, Cho KR. Bilateral Salpingo-Oophorectomy Is Superior to Salpingectomy Alone in Preventing Non-Tubal Tumor Development in a Mouse Model of High-Grade Serous Carcinoma. Cancers (Basel). 2025;17:2759. https:\/\/doi.org\/10.3390\/cancers17172759.","journal-title":"Cancers (Basel)"},{"key":"816_CR296","doi-asserted-by":"publisher","first-page":"931387","DOI":"10.3389\/fcell.2022.931387","volume":"10","author":"FB Aksoy Yasar","year":"2022","unstructured":"Aksoy Yasar FB, Shingu T, Zamler DB, Zaman MF, Chien DL, Zhang Q, et al. Quaking but not parkin is the major tumor suppressor in 6q deleted region in glioblastoma. Front Cell Dev Biol. 2022;10:931387. https:\/\/doi.org\/10.3389\/fcell.2022.931387.","journal-title":"Front Cell Dev Biol"},{"key":"816_CR297","doi-asserted-by":"publisher","DOI":"10.1101\/2024.12.18.628714","author":"MZ Zannikou","year":"2025","unstructured":"Zannikou MZ, Duffy JT, Procissi D, Najem H, Levine RN, Hambardzumyan D, et al. A Bi-Specific T Cell-Engaging Antibody Shows Potent Activity, Specificity, and Tumor Microenvironment Remodeling in Experimental Syngeneic and Genetically Engineered Models of GBM. bioRxiv. 2025. https:\/\/doi.org\/10.1101\/2024.12.18.628714.","journal-title":"bioRxiv"},{"key":"816_CR298","doi-asserted-by":"publisher","first-page":"D1391","DOI":"10.1093\/nar\/gkab804","volume":"50","author":"Z Zeng","year":"2022","unstructured":"Zeng Z, Wong CJ, Yang L, Ouardaoui N, Li D, Zhang W, et al. TISMO: syngeneic mouse tumor database to model tumor immunity and immunotherapy response. Nucleic Acids Res. 2022;50:D1391\u20137. https:\/\/doi.org\/10.1093\/nar\/gkab804.","journal-title":"Nucleic Acids Res"},{"key":"816_CR299","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1038\/s42003-023-05529-z","volume":"6","author":"DP Cook","year":"2023","unstructured":"Cook DP, Galpin KJC, Rodriguez GM, Shakfa N, Wilson-Sanchez J, Echaibi M, et al. Comparative analysis of syngeneic mouse models of high-grade serous ovarian cancer. Commun Biol. 2023;6:1152. https:\/\/doi.org\/10.1038\/s42003-023-05529-z.","journal-title":"Commun Biol"},{"key":"816_CR300","doi-asserted-by":"publisher","first-page":"e005583","DOI":"10.1136\/jitc-2022-005583","volume":"11","author":"X Dong","year":"2023","unstructured":"Dong X, Ren J, Amoozgar Z, Lee S, Datta M, Roberge S, et al. Anti-VEGF therapy improves EGFR-vIII-CAR-T cell delivery and efficacy in syngeneic glioblastoma models in mice. J Immunother Cancer. 2023;11:e005583. https:\/\/doi.org\/10.1136\/jitc-2022-005583.","journal-title":"J Immunother Cancer"},{"key":"816_CR301","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s00401-024-02831-w","volume":"148","author":"N Mikolajewicz","year":"2024","unstructured":"Mikolajewicz N, Tatari N, Wei J, Savage N, Granda Farias A, Dimitrov V, et al. Functional profiling of murine glioma models highlights targetable immune evasion phenotypes. Acta Neuropathol. 2024;148:74. https:\/\/doi.org\/10.1007\/s00401-024-02831-w.","journal-title":"Acta Neuropathol"},{"key":"816_CR302","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/978-1-0716-3585-8_11","volume":"2746","author":"P Kaminska","year":"2024","unstructured":"Kaminska P, Cyranowski S, Pilanc P, Malik AR. Syngeneic Mouse Model of Glioblastoma: Intracranial Implantation of GL261 Cells. Methods Mol Biol. 2024;2746:135\u201346. https:\/\/doi.org\/10.1007\/978-1-0716-3585-8_11.","journal-title":"Methods Mol Biol"},{"key":"816_CR303","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.2147\/IJN.S241055","volume":"15","author":"N Grafals-Ruiz","year":"2020","unstructured":"Grafals-Ruiz N, Rios-Vicil CI, Lozada-Delgado EL, Qui\u00f1ones-D\u00edaz BI, Noriega-Rivera RA, Mart\u00ednez-Zayas G, et al. Brain Targeted Gold Liposomes Improve RNAi Delivery for Glioblastoma. Int J Nanomed. 2020;15:2809\u201328. https:\/\/doi.org\/10.2147\/IJN.S241055.","journal-title":"Int J Nanomed"},{"key":"816_CR304","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1158\/2326-6066.CIR-24-1046","volume":"13","author":"N Lonberg","year":"2025","unstructured":"Lonberg N. The Problem with Syngeneic Mouse Tumor Models. Cancer Immunol Res. 2025;13:456\u201362. https:\/\/doi.org\/10.1158\/2326-6066.CIR-24-1046.","journal-title":"Cancer Immunol Res"},{"key":"816_CR305","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.jpba.2017.11.047","volume":"149","author":"Y-L Lin","year":"2018","unstructured":"Lin Y-L, Wu M-T, Yang F-Y. Pharmacokinetics of doxorubicin in glioblastoma multiforme following ultrasound-Induced blood-brain barrier disruption as determined by microdialysis. J Pharm Biomed Anal. 2018;149:482\u20137. https:\/\/doi.org\/10.1016\/j.jpba.2017.11.047.","journal-title":"J Pharm Biomed Anal"},{"key":"816_CR306","doi-asserted-by":"publisher","first-page":"e45468","DOI":"10.1371\/journal.pone.0045468","volume":"7","author":"F-Y Yang","year":"2012","unstructured":"Yang F-Y, Wang H-E, Liu R-S, Teng M-C, Li J-J, Lu M, et al. Pharmacokinetic analysis of 111 in-labeled liposomal Doxorubicin in murine glioblastoma after blood-brain barrier disruption by focused ultrasound. PLoS ONE. 2012;7:e45468. https:\/\/doi.org\/10.1371\/journal.pone.0045468.","journal-title":"PLoS ONE"},{"key":"816_CR307","doi-asserted-by":"publisher","first-page":"e82331","DOI":"10.1371\/journal.pone.0082331","volume":"9","author":"PJ Gaillard","year":"2014","unstructured":"Gaillard PJ, Appeldoorn CCM, Dorland R, van Kregten J, Manca F, Vugts DJ, et al. Pharmacokinetics, brain delivery, and efficacy in brain tumor-bearing mice of glutathione pegylated liposomal doxorubicin (2B3-101). PLoS ONE. 2014;9:e82331. https:\/\/doi.org\/10.1371\/journal.pone.0082331.","journal-title":"PLoS ONE"},{"key":"816_CR308","doi-asserted-by":"publisher","first-page":"100184","DOI":"10.1016\/j.xcrm.2020.100184","volume":"2","author":"MC de Gooijer","year":"2021","unstructured":"de Gooijer MC, Kemper EM, Buil LCM, \u00c7itirikkaya CH, Buckle T, Beijnen JH, et al. ATP-binding cassette transporters restrict drug delivery and efficacy against brain tumors even when blood-brain barrier integrity is lost. Cell Rep Med. 2021;2:100184. https:\/\/doi.org\/10.1016\/j.xcrm.2020.100184.","journal-title":"Cell Rep Med"},{"key":"816_CR309","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1158\/1078-0432.CCR-14-0084","volume":"20","author":"F Lin","year":"2014","unstructured":"Lin F, de Gooijer MC, Roig EM, Buil LCM, Christner SM, Beumer JH, et al. ABCB1, ABCG2, and PTEN determine the response of glioblastoma to temozolomide and ABT-888 therapy. Clin Cancer Res. 2014;20:2703\u201313. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-0084.","journal-title":"Clin Cancer Res"},{"key":"816_CR310","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1124\/jpet.113.208959","volume":"347","author":"RK Oberoi","year":"2013","unstructured":"Oberoi RK, Mittapalli RK, Elmquist WF. Pharmacokinetic assessment of efflux transport in sunitinib distribution to the brain. J Pharmacol Exp Ther. 2013;347:755\u201364. https:\/\/doi.org\/10.1124\/jpet.113.208959.","journal-title":"J Pharmacol Exp Ther"},{"key":"816_CR311","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/ijc.31052","volume":"142","author":"MC de Gooijer","year":"2018","unstructured":"de Gooijer MC, Zhang P, Weijer R, Buil LCM, Beijnen JH, van Tellingen O. The impact of P-glycoprotein and breast cancer resistance protein on the brain pharmacokinetics and pharmacodynamics of a panel of MEK inhibitors. Int J Cancer. 2018;142:381\u201391. https:\/\/doi.org\/10.1002\/ijc.31052.","journal-title":"Int J Cancer"},{"key":"816_CR312","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1124\/dmd.112.048322","volume":"41","author":"S Agarwal","year":"2013","unstructured":"Agarwal S, Manchanda P, Vogelbaum MA, Ohlfest JR, Elmquist WF. Function of the blood-brain barrier and restriction of drug delivery to invasive glioma cells: findings in an orthotopic rat xenograft model of glioma. Drug Metab Dispos. 2013;41:33\u20139. https:\/\/doi.org\/10.1124\/dmd.112.048322.","journal-title":"Drug Metab Dispos"},{"key":"816_CR313","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1021\/acs.molpharmaceut.9b00018","volume":"16","author":"IC Salaroglio","year":"2019","unstructured":"Salaroglio IC, Abate C, Rolando B, Battaglia L, Gazzano E, Colombino E, et al. Validation of Thiosemicarbazone Compounds as P-Glycoprotein Inhibitors in Human Primary Brain-Blood Barrier and Glioblastoma Stem Cells. Mol Pharm. 2019;16:3361\u201373. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.9b00018.","journal-title":"Mol Pharm"},{"key":"816_CR314","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s11060-009-0008-0","volume":"97","author":"M Holdhoff","year":"2010","unstructured":"Holdhoff M, Supko JG, Gallia GL, Hann CL, Bonekamp D, Ye X, et al. Intratumoral concentrations of imatinib after oral administration in patients with glioblastoma multiforme. J Neurooncol. 2010;97:241\u20135. https:\/\/doi.org\/10.1007\/s11060-009-0008-0.","journal-title":"J Neurooncol"},{"key":"816_CR315","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1093\/neuonc\/noaf204","volume":"28","author":"J-H Oh","year":"2026","unstructured":"Oh J-H, Reed SK, Riviere-Cazaux C, Kim M, Mladek AC, Illamola SM, et al. Window of opportunity evaluation of blood-brain barrier permeability heterogeneity within and across high-grade glioma patients. Neuro Oncol. 2026;28:130\u201342. https:\/\/doi.org\/10.1093\/neuonc\/noaf204.","journal-title":"Neuro Oncol"},{"key":"816_CR316","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.ccell.2016.03.002","volume":"29","author":"TN Phoenix","year":"2016","unstructured":"Phoenix TN, Patmore DM, Boop S, Boulos N, Jacus MO, Patel YT, et al. Medulloblastoma Genotype Dictates Blood Brain Barrier Phenotype. Cancer Cell. 2016;29:508\u201322. https:\/\/doi.org\/10.1016\/j.ccell.2016.03.002.","journal-title":"Cancer Cell"}],"container-title":["Fluids and Barriers of the CNS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12987-026-00816-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-026-00816-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-026-00816-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T16:05:46Z","timestamp":1783353946000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12987-026-00816-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":316,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["816"],"URL":"https:\/\/doi.org\/10.1186\/s12987-026-00816-3","relation":{"references":[{"id-type":"doi","id":"10.3390\/ijms22126385","asserted-by":"subject"},{"id-type":"doi","id":"10.3389\/fphys.2020.00830","asserted-by":"subject"}]},"ISSN":["2045-8118"],"issn-type":[{"value":"2045-8118","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"assertion":[{"value":"21 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate and consent for pub<!--Emphasis Type='Bold' removed-->lication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"87"}}